CN108697143A - Including 3-O- galloyls -3,3 ', the Hydra composition of 5,5 ', 7- penta hydroxy group flavane - Google Patents
Including 3-O- galloyls -3,3 ', the Hydra composition of 5,5 ', 7- penta hydroxy group flavane Download PDFInfo
- Publication number
- CN108697143A CN108697143A CN201780013667.7A CN201780013667A CN108697143A CN 108697143 A CN108697143 A CN 108697143A CN 201780013667 A CN201780013667 A CN 201780013667A CN 108697143 A CN108697143 A CN 108697143A
- Authority
- CN
- China
- Prior art keywords
- weight
- composition
- galloyl
- less
- fraction
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000000203 mixture Substances 0.000 title claims abstract description 89
- QOLIPNRNLBQTAU-UHFFFAOYSA-N flavan Chemical compound C1CC2=CC=CC=C2OC1C1=CC=CC=C1 QOLIPNRNLBQTAU-UHFFFAOYSA-N 0.000 title claims abstract description 44
- 125000002887 hydroxy group Chemical group [H]O* 0.000 title claims abstract description 44
- QRXWMOHMRWLFEY-UHFFFAOYSA-N isoniazide Chemical compound NNC(=O)C1=CC=NC=C1 QRXWMOHMRWLFEY-UHFFFAOYSA-N 0.000 title claims abstract description 9
- 241000243251 Hydra Species 0.000 title claims abstract description 8
- 235000019225 fermented tea Nutrition 0.000 claims abstract description 37
- 150000003839 salts Chemical class 0.000 claims abstract description 34
- 150000002576 ketones Chemical class 0.000 claims abstract description 26
- 239000012453 solvate Substances 0.000 claims abstract description 15
- 229940002612 prodrug Drugs 0.000 claims abstract description 14
- 239000000651 prodrug Substances 0.000 claims abstract description 14
- 239000004480 active ingredient Substances 0.000 claims abstract description 13
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical group CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 claims description 77
- 239000000126 substance Substances 0.000 claims description 23
- 239000002537 cosmetic Substances 0.000 claims description 14
- 235000013305 food Nutrition 0.000 claims description 9
- 239000000284 extract Substances 0.000 claims description 5
- 239000008194 pharmaceutical composition Substances 0.000 claims description 3
- 150000001335 aliphatic alkanes Chemical class 0.000 claims 1
- ODHOTFAKXJWQIS-UHFFFAOYSA-N (3‘«÷‘«÷S)-[3,3‘«÷,4‘«÷,5,7-Pentahydroxyflavan(4·8)]2-3,3‘«÷,4‘«÷,5,7-pentahydroxyflavan(2·7,4·8)-3,3‘«÷,4‘«÷,5,7-pentahydroxyflavan(4·8)-3,3‘«÷,4‘«÷,5,7-pentahydroxyflavan Natural products C=12OC(C=3C=C(O)C(O)=CC=3)C(O)CC2=C(O)C=C(O)C=1C1C(O)C(C=2C=C(O)C(O)=CC=2)OC(C=2C(C3O)C4=C(O)C=C5O)=C1C(O)=CC=2OC3(C=1C=C(O)C(O)=CC=1)OC4=C5C(C1=C(O)C=C2O)C(O)C(C=3C=C(O)C(O)=CC=3)OC1=C2C(C1=C(O)C=C(O)C=C1O1)C(O)C1C1=CC=C(O)C(O)=C1 ODHOTFAKXJWQIS-UHFFFAOYSA-N 0.000 abstract description 10
- 210000003491 skin Anatomy 0.000 description 31
- 239000002552 dosage form Substances 0.000 description 26
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 24
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 15
- 238000004519 manufacturing process Methods 0.000 description 15
- 239000004615 ingredient Substances 0.000 description 14
- 230000003020 moisturizing effect Effects 0.000 description 14
- 150000001875 compounds Chemical class 0.000 description 13
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 12
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 12
- 238000002360 preparation method Methods 0.000 description 12
- -1 Hydroxyl flavane Chemical compound 0.000 description 10
- 239000003795 chemical substances by application Substances 0.000 description 9
- 238000000034 method Methods 0.000 description 9
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 8
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 8
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 8
- RYYVLZVUVIJVGH-UHFFFAOYSA-N caffeine Chemical compound CN1C(=O)N(C)C(=O)C2=C1N=CN2C RYYVLZVUVIJVGH-UHFFFAOYSA-N 0.000 description 8
- 239000007788 liquid Substances 0.000 description 8
- 239000002904 solvent Substances 0.000 description 8
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 7
- 244000269722 Thea sinensis Species 0.000 description 7
- 239000002253 acid Substances 0.000 description 7
- 239000006071 cream Substances 0.000 description 7
- 239000003814 drug Substances 0.000 description 7
- 235000013402 health food Nutrition 0.000 description 7
- 239000006210 lotion Substances 0.000 description 7
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 6
- 238000005481 NMR spectroscopy Methods 0.000 description 6
- 235000013361 beverage Nutrition 0.000 description 6
- 235000019441 ethanol Nutrition 0.000 description 6
- 239000008187 granular material Substances 0.000 description 6
- 235000001497 healthy food Nutrition 0.000 description 6
- 239000007924 injection Substances 0.000 description 6
- 238000002347 injection Methods 0.000 description 6
- 239000000843 powder Substances 0.000 description 6
- 239000007901 soft capsule Substances 0.000 description 6
- 229930003231 vitamin Natural products 0.000 description 6
- 235000013343 vitamin Nutrition 0.000 description 6
- 239000011782 vitamin Substances 0.000 description 6
- 229940088594 vitamin Drugs 0.000 description 6
- 150000003722 vitamin derivatives Chemical class 0.000 description 6
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 5
- 229930003268 Vitamin C Natural products 0.000 description 5
- 235000015165 citric acid Nutrition 0.000 description 5
- 238000007796 conventional method Methods 0.000 description 5
- 229940079593 drug Drugs 0.000 description 5
- 230000000694 effects Effects 0.000 description 5
- 238000011049 filling Methods 0.000 description 5
- 230000006870 function Effects 0.000 description 5
- 239000000499 gel Substances 0.000 description 5
- 238000009499 grossing Methods 0.000 description 5
- 238000004128 high performance liquid chromatography Methods 0.000 description 5
- 239000000463 material Substances 0.000 description 5
- 239000003002 pH adjusting agent Substances 0.000 description 5
- 239000003755 preservative agent Substances 0.000 description 5
- 235000019154 vitamin C Nutrition 0.000 description 5
- 239000011718 vitamin C Substances 0.000 description 5
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 4
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 4
- LPHGQDQBBGAPDZ-UHFFFAOYSA-N Isocaffeine Natural products CN1C(=O)N(C)C(=O)C2=C1N(C)C=N2 LPHGQDQBBGAPDZ-UHFFFAOYSA-N 0.000 description 4
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 4
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 4
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 4
- 229930003427 Vitamin E Natural products 0.000 description 4
- 239000002585 base Substances 0.000 description 4
- WPYMKLBDIGXBTP-UHFFFAOYSA-N benzoic acid Chemical compound OC(=O)C1=CC=CC=C1 WPYMKLBDIGXBTP-UHFFFAOYSA-N 0.000 description 4
- 210000000481 breast Anatomy 0.000 description 4
- 229960001948 caffeine Drugs 0.000 description 4
- VJEONQKOZGKCAK-UHFFFAOYSA-N caffeine Natural products CN1C(=O)N(C)C(=O)C2=C1C=CN2C VJEONQKOZGKCAK-UHFFFAOYSA-N 0.000 description 4
- ULDHMXUKGWMISQ-UHFFFAOYSA-N carvone Chemical compound CC(=C)C1CC=C(C)C(=O)C1 ULDHMXUKGWMISQ-UHFFFAOYSA-N 0.000 description 4
- JHIVVAPYMSGYDF-UHFFFAOYSA-N cyclohexyloxide Natural products O=C1CCCCC1 JHIVVAPYMSGYDF-UHFFFAOYSA-N 0.000 description 4
- XBDQKXXYIPTUBI-UHFFFAOYSA-N dimethylselenoniopropionate Natural products CCC(O)=O XBDQKXXYIPTUBI-UHFFFAOYSA-N 0.000 description 4
- 150000002148 esters Chemical class 0.000 description 4
- 230000001815 facial effect Effects 0.000 description 4
- 238000000855 fermentation Methods 0.000 description 4
- 230000004151 fermentation Effects 0.000 description 4
- 239000012530 fluid Substances 0.000 description 4
- 239000006260 foam Substances 0.000 description 4
- 238000005194 fractionation Methods 0.000 description 4
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 4
- 239000008103 glucose Substances 0.000 description 4
- 150000002500 ions Chemical class 0.000 description 4
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 4
- HQKMJHAJHXVSDF-UHFFFAOYSA-L magnesium stearate Chemical compound [Mg+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O HQKMJHAJHXVSDF-UHFFFAOYSA-L 0.000 description 4
- 230000002335 preservative effect Effects 0.000 description 4
- 239000000523 sample Substances 0.000 description 4
- 239000000243 solution Substances 0.000 description 4
- 235000013616 tea Nutrition 0.000 description 4
- 235000019165 vitamin E Nutrition 0.000 description 4
- 229940046009 vitamin E Drugs 0.000 description 4
- 239000011709 vitamin E Substances 0.000 description 4
- AXPZIVKEZRHGAS-UHFFFAOYSA-N 3-benzyl-5-[(2-nitrophenoxy)methyl]oxolan-2-one Chemical compound [O-][N+](=O)C1=CC=CC=C1OCC1OC(=O)C(CC=2C=CC=CC=2)C1 AXPZIVKEZRHGAS-UHFFFAOYSA-N 0.000 description 3
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 3
- OFOBLEOULBTSOW-UHFFFAOYSA-N Malonic acid Chemical compound OC(=O)CC(O)=O OFOBLEOULBTSOW-UHFFFAOYSA-N 0.000 description 3
- 239000004909 Moisturizer Substances 0.000 description 3
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 description 3
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 3
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- 210000004027 cell Anatomy 0.000 description 3
- 201000010099 disease Diseases 0.000 description 3
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 3
- 238000001035 drying Methods 0.000 description 3
- 235000013399 edible fruits Nutrition 0.000 description 3
- 229930003935 flavonoid Natural products 0.000 description 3
- 150000002215 flavonoids Chemical class 0.000 description 3
- 235000017173 flavonoids Nutrition 0.000 description 3
- HNZUNIKWNYHEJJ-UHFFFAOYSA-N geranyl acetone Natural products CC(C)=CCCC(C)=CCCC(C)=O HNZUNIKWNYHEJJ-UHFFFAOYSA-N 0.000 description 3
- 235000011187 glycerol Nutrition 0.000 description 3
- FUZZWVXGSFPDMH-UHFFFAOYSA-N hexanoic acid Chemical compound CCCCCC(O)=O FUZZWVXGSFPDMH-UHFFFAOYSA-N 0.000 description 3
- 229910052500 inorganic mineral Inorganic materials 0.000 description 3
- 239000008101 lactose Substances 0.000 description 3
- 235000010755 mineral Nutrition 0.000 description 3
- 239000011707 mineral Substances 0.000 description 3
- 230000001333 moisturizer Effects 0.000 description 3
- 239000002674 ointment Substances 0.000 description 3
- 229920001542 oligosaccharide Polymers 0.000 description 3
- 150000002482 oligosaccharides Chemical class 0.000 description 3
- 230000001575 pathological effect Effects 0.000 description 3
- XNLICIUVMPYHGG-UHFFFAOYSA-N pentan-2-one Chemical compound CCCC(C)=O XNLICIUVMPYHGG-UHFFFAOYSA-N 0.000 description 3
- 239000007921 spray Substances 0.000 description 3
- 239000003381 stabilizer Substances 0.000 description 3
- NZGWDASTMWDZIW-MRVPVSSYSA-N (+)-pulegone Chemical compound C[C@@H]1CCC(=C(C)C)C(=O)C1 NZGWDASTMWDZIW-MRVPVSSYSA-N 0.000 description 2
- VBICKXHEKHSIBG-UHFFFAOYSA-N 1-monostearoylglycerol Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(O)CO VBICKXHEKHSIBG-UHFFFAOYSA-N 0.000 description 2
- OWEGMIWEEQEYGQ-UHFFFAOYSA-N 100676-05-9 Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC2C(OC(O)C(O)C2O)CO)O1 OWEGMIWEEQEYGQ-UHFFFAOYSA-N 0.000 description 2
- MIDXCONKKJTLDX-UHFFFAOYSA-N 3,5-dimethylcyclopentane-1,2-dione Chemical compound CC1CC(C)C(=O)C1=O MIDXCONKKJTLDX-UHFFFAOYSA-N 0.000 description 2
- SYBYTAAJFKOIEJ-UHFFFAOYSA-N 3-Methylbutan-2-one Chemical compound CC(C)C(C)=O SYBYTAAJFKOIEJ-UHFFFAOYSA-N 0.000 description 2
- HCFAJYNVAYBARA-UHFFFAOYSA-N 4-heptanone Chemical compound CCCC(=O)CCC HCFAJYNVAYBARA-UHFFFAOYSA-N 0.000 description 2
- AANMVENRNJYEMK-UHFFFAOYSA-N 4-propan-2-ylcyclohex-2-en-1-one Chemical compound CC(C)C1CCC(=O)C=C1 AANMVENRNJYEMK-UHFFFAOYSA-N 0.000 description 2
- KWOLFJPFCHCOCG-UHFFFAOYSA-N Acetophenone Chemical compound CC(=O)C1=CC=CC=C1 KWOLFJPFCHCOCG-UHFFFAOYSA-N 0.000 description 2
- 244000063299 Bacillus subtilis Species 0.000 description 2
- 239000005711 Benzoic acid Substances 0.000 description 2
- 102000008186 Collagen Human genes 0.000 description 2
- 108010035532 Collagen Proteins 0.000 description 2
- 229920002261 Corn starch Polymers 0.000 description 2
- RGHNJXZEOKUKBD-SQOUGZDYSA-N D-gluconic acid Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C(O)=O RGHNJXZEOKUKBD-SQOUGZDYSA-N 0.000 description 2
- FEWJPZIEWOKRBE-JCYAYHJZSA-N Dextrotartaric acid Chemical compound OC(=O)[C@H](O)[C@@H](O)C(O)=O FEWJPZIEWOKRBE-JCYAYHJZSA-N 0.000 description 2
- 102000004190 Enzymes Human genes 0.000 description 2
- 108090000790 Enzymes Proteins 0.000 description 2
- LHXDLQBQYFFVNW-UHFFFAOYSA-N Fenchone Chemical compound C1CC2(C)C(=O)C(C)(C)C1C2 LHXDLQBQYFFVNW-UHFFFAOYSA-N 0.000 description 2
- VZCYOOQTPOCHFL-OWOJBTEDSA-N Fumaric acid Chemical compound OC(=O)\C=C\C(O)=O VZCYOOQTPOCHFL-OWOJBTEDSA-N 0.000 description 2
- GUBGYTABKSRVRQ-PICCSMPSSA-N Maltose Natural products O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@@H](CO)OC(O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-PICCSMPSSA-N 0.000 description 2
- AFVFQIVMOAPDHO-UHFFFAOYSA-N Methanesulfonic acid Chemical compound CS(O)(=O)=O AFVFQIVMOAPDHO-UHFFFAOYSA-N 0.000 description 2
- BZLVMXJERCGZMT-UHFFFAOYSA-N Methyl tert-butyl ether Chemical compound COC(C)(C)C BZLVMXJERCGZMT-UHFFFAOYSA-N 0.000 description 2
- NZGWDASTMWDZIW-UHFFFAOYSA-N Pulegone Natural products CC1CCC(=C(C)C)C(=O)C1 NZGWDASTMWDZIW-UHFFFAOYSA-N 0.000 description 2
- 229920002472 Starch Polymers 0.000 description 2
- FEWJPZIEWOKRBE-UHFFFAOYSA-N Tartaric acid Natural products [H+].[H+].[O-]C(=O)C(O)C(O)C([O-])=O FEWJPZIEWOKRBE-UHFFFAOYSA-N 0.000 description 2
- 230000002411 adverse Effects 0.000 description 2
- USMNOWBWPHYOEA-UHFFFAOYSA-N alpha-thujone Natural products CC1C(=O)CC2(C(C)C)C1C2 USMNOWBWPHYOEA-UHFFFAOYSA-N 0.000 description 2
- 229910000147 aluminium phosphate Inorganic materials 0.000 description 2
- 239000012752 auxiliary agent Substances 0.000 description 2
- 230000004888 barrier function Effects 0.000 description 2
- 235000010233 benzoic acid Nutrition 0.000 description 2
- 239000002775 capsule Substances 0.000 description 2
- 235000013736 caramel Nutrition 0.000 description 2
- 230000008859 change Effects 0.000 description 2
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 2
- 239000011248 coating agent Substances 0.000 description 2
- 238000000576 coating method Methods 0.000 description 2
- 229920001436 collagen Polymers 0.000 description 2
- 239000003086 colorant Substances 0.000 description 2
- 239000008120 corn starch Substances 0.000 description 2
- 229940099112 cornstarch Drugs 0.000 description 2
- 238000004185 countercurrent chromatography Methods 0.000 description 2
- 239000013078 crystal Substances 0.000 description 2
- OSOIQJGOYGSIMF-UHFFFAOYSA-N cyclopentadecanone Chemical compound O=C1CCCCCCCCCCCCCC1 OSOIQJGOYGSIMF-UHFFFAOYSA-N 0.000 description 2
- BGTOWKSIORTVQH-UHFFFAOYSA-N cyclopentanone Chemical compound O=C1CCCC1 BGTOWKSIORTVQH-UHFFFAOYSA-N 0.000 description 2
- 238000004945 emulsification Methods 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 210000002615 epidermis Anatomy 0.000 description 2
- 239000003205 fragrance Substances 0.000 description 2
- 239000013538 functional additive Substances 0.000 description 2
- 235000009569 green tea Nutrition 0.000 description 2
- CATSNJVOTSVZJV-UHFFFAOYSA-N heptan-2-one Chemical compound CCCCCC(C)=O CATSNJVOTSVZJV-UHFFFAOYSA-N 0.000 description 2
- NGAZZOYFWWSOGK-UHFFFAOYSA-N heptan-3-one Chemical compound CCCCC(=O)CC NGAZZOYFWWSOGK-UHFFFAOYSA-N 0.000 description 2
- 230000000887 hydrating effect Effects 0.000 description 2
- 229930002839 ionone Natural products 0.000 description 2
- 150000002499 ionone derivatives Chemical class 0.000 description 2
- 210000002510 keratinocyte Anatomy 0.000 description 2
- 150000002561 ketenes Chemical class 0.000 description 2
- 239000004310 lactic acid Substances 0.000 description 2
- 235000014655 lactic acid Nutrition 0.000 description 2
- 150000002632 lipids Chemical class 0.000 description 2
- 235000019359 magnesium stearate Nutrition 0.000 description 2
- VLKZOEOYAKHREP-UHFFFAOYSA-N methyl pentane Natural products CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 2
- TXXHDPDFNKHHGW-UHFFFAOYSA-N muconic acid Chemical compound OC(=O)C=CC=CC(O)=O TXXHDPDFNKHHGW-UHFFFAOYSA-N 0.000 description 2
- 230000003287 optical effect Effects 0.000 description 2
- 150000007524 organic acids Chemical class 0.000 description 2
- 229930007459 p-menth-8-en-3-one Natural products 0.000 description 2
- 230000036961 partial effect Effects 0.000 description 2
- 239000002245 particle Substances 0.000 description 2
- FDPIMTJIUBPUKL-UHFFFAOYSA-N pentan-3-one Chemical compound CCC(=O)CC FDPIMTJIUBPUKL-UHFFFAOYSA-N 0.000 description 2
- 239000002304 perfume Substances 0.000 description 2
- 239000006187 pill Substances 0.000 description 2
- 230000008569 process Effects 0.000 description 2
- 235000019260 propionic acid Nutrition 0.000 description 2
- JXJIQCXXJGRKRJ-KOOBJXAQSA-N pseudoionone Chemical compound CC(C)=CCC\C(C)=C\C=C\C(C)=O JXJIQCXXJGRKRJ-KOOBJXAQSA-N 0.000 description 2
- 230000008591 skin barrier function Effects 0.000 description 2
- 239000002884 skin cream Substances 0.000 description 2
- 239000011780 sodium chloride Substances 0.000 description 2
- 239000008107 starch Substances 0.000 description 2
- 235000019698 starch Nutrition 0.000 description 2
- 230000001954 sterilising effect Effects 0.000 description 2
- 239000004094 surface-active agent Substances 0.000 description 2
- 239000000375 suspending agent Substances 0.000 description 2
- 239000011975 tartaric acid Substances 0.000 description 2
- 235000002906 tartaric acid Nutrition 0.000 description 2
- XOAAWQZATWQOTB-UHFFFAOYSA-N taurine Chemical compound NCCS(O)(=O)=O XOAAWQZATWQOTB-UHFFFAOYSA-N 0.000 description 2
- VZCYOOQTPOCHFL-UHFFFAOYSA-N trans-butenedioic acid Natural products OC(=O)C=CC(O)=O VZCYOOQTPOCHFL-UHFFFAOYSA-N 0.000 description 2
- 238000011282 treatment Methods 0.000 description 2
- 239000003643 water by type Substances 0.000 description 2
- LHXDLQBQYFFVNW-XCBNKYQSSA-N (+)-Fenchone Natural products C1C[C@]2(C)C(=O)C(C)(C)[C@H]1C2 LHXDLQBQYFFVNW-XCBNKYQSSA-N 0.000 description 1
- PFTAWBLQPZVEMU-DZGCQCFKSA-N (+)-catechin Chemical compound C1([C@H]2OC3=CC(O)=CC(O)=C3C[C@@H]2O)=CC=C(O)C(O)=C1 PFTAWBLQPZVEMU-DZGCQCFKSA-N 0.000 description 1
- LHXDLQBQYFFVNW-OIBJUYFYSA-N (-)-Fenchone Chemical compound C1C[C@@]2(C)C(=O)C(C)(C)[C@@H]1C2 LHXDLQBQYFFVNW-OIBJUYFYSA-N 0.000 description 1
- QBYIENPQHBMVBV-HFEGYEGKSA-N (2R)-2-hydroxy-2-phenylacetic acid Chemical compound O[C@@H](C(O)=O)c1ccccc1.O[C@@H](C(O)=O)c1ccccc1 QBYIENPQHBMVBV-HFEGYEGKSA-N 0.000 description 1
- BWSWZBCSFZAYOB-CABCVRRESA-N (2s,4r)-1-dodecanoyl-4-hydroxypyrrolidine-2-carboxylic acid Chemical compound CCCCCCCCCCCC(=O)N1C[C@H](O)C[C@H]1C(O)=O BWSWZBCSFZAYOB-CABCVRRESA-N 0.000 description 1
- VCOCESNMLNDPLX-BTXGZQJSSA-N (3s,6s)-2,2,8,8-tetramethyl-octahydro-1h-2,4a-methanonapthalene-10-one Chemical compound O=C1CCC(C)(C)[C@@]2(C3)C1C(C)(C)[C@H]3CC2 VCOCESNMLNDPLX-BTXGZQJSSA-N 0.000 description 1
- YYGNTYWPHWGJRM-UHFFFAOYSA-N (6E,10E,14E,18E)-2,6,10,15,19,23-hexamethyltetracosa-2,6,10,14,18,22-hexaene Chemical compound CC(C)=CCCC(C)=CCCC(C)=CCCC=C(C)CCC=C(C)CCC=C(C)C YYGNTYWPHWGJRM-UHFFFAOYSA-N 0.000 description 1
- 239000001211 (E)-4-phenylbut-3-en-2-one Substances 0.000 description 1
- ULDHMXUKGWMISQ-VIFPVBQESA-N (S)-(+)-Carvone Natural products CC(=C)[C@H]1CC=C(C)C(=O)C1 ULDHMXUKGWMISQ-VIFPVBQESA-N 0.000 description 1
- MIOPJNTWMNEORI-GMSGAONNSA-N (S)-camphorsulfonic acid Chemical compound C1C[C@@]2(CS(O)(=O)=O)C(=O)C[C@@H]1C2(C)C MIOPJNTWMNEORI-GMSGAONNSA-N 0.000 description 1
- BJEPYKJPYRNKOW-REOHCLBHSA-N (S)-malic acid Chemical compound OC(=O)[C@@H](O)CC(O)=O BJEPYKJPYRNKOW-REOHCLBHSA-N 0.000 description 1
- PBKBMLILZYXPBO-CSKARUKUSA-N (e)-3-methyl-4-(2,4,6-trimethylcyclohex-3-en-1-yl)but-3-en-2-one Chemical compound CC1CC(C)=CC(C)C1\C=C(/C)C(C)=O PBKBMLILZYXPBO-CSKARUKUSA-N 0.000 description 1
- FETSKTIMHFKZNF-AATRIKPKSA-N (e)-4-(2,4,6-trimethylcyclohex-3-en-1-yl)but-3-en-2-one Chemical compound CC1CC(C)=CC(C)C1\C=C\C(C)=O FETSKTIMHFKZNF-AATRIKPKSA-N 0.000 description 1
- WBYWAXJHAXSJNI-VOTSOKGWSA-M .beta-Phenylacrylic acid Natural products [O-]C(=O)\C=C\C1=CC=CC=C1 WBYWAXJHAXSJNI-VOTSOKGWSA-M 0.000 description 1
- FXCYGAGBPZQRJE-ZHACJKMWSA-N 1-(2,6,6-Trimethyl-2-cyclohexen-1-yl)-1,6-heptadien-3-one Chemical compound CC1=CCCC(C)(C)C1\C=C\C(=O)CCC=C FXCYGAGBPZQRJE-ZHACJKMWSA-N 0.000 description 1
- DZSVIVLGBJKQAP-UHFFFAOYSA-N 1-(2-methyl-5-propan-2-ylcyclohex-2-en-1-yl)propan-1-one Chemical compound CCC(=O)C1CC(C(C)C)CC=C1C DZSVIVLGBJKQAP-UHFFFAOYSA-N 0.000 description 1
- SLDQOBRACOQXGE-QPJJXVBHSA-N 1-(4-methoxyphenyl)-1-penten-3-one Chemical compound CCC(=O)\C=C\C1=CC=C(OC)C=C1 SLDQOBRACOQXGE-QPJJXVBHSA-N 0.000 description 1
- SLNPSLWTEUJUGY-UHFFFAOYSA-N 1-(cyclopenten-1-yl)ethanone Chemical compound CC(=O)C1=CCCC1 SLNPSLWTEUJUGY-UHFFFAOYSA-N 0.000 description 1
- QQLIGMASAVJVON-UHFFFAOYSA-N 1-naphthalen-1-ylethanone Chemical compound C1=CC=C2C(C(=O)C)=CC=CC2=C1 QQLIGMASAVJVON-UHFFFAOYSA-N 0.000 description 1
- MOMFXATYAINJML-UHFFFAOYSA-N 2-Acetylthiazole Chemical group CC(=O)C1=NC=CS1 MOMFXATYAINJML-UHFFFAOYSA-N 0.000 description 1
- RQXTZKGDMNIWJF-UHFFFAOYSA-N 2-butan-2-ylcyclohexan-1-one Chemical group CCC(C)C1CCCCC1=O RQXTZKGDMNIWJF-UHFFFAOYSA-N 0.000 description 1
- POYYYXPQBFPUKS-UHFFFAOYSA-N 2-butylcyclohexan-1-one Chemical group CCCCC1CCCCC1=O POYYYXPQBFPUKS-UHFFFAOYSA-N 0.000 description 1
- JTHVYOIHZNYRCC-UHFFFAOYSA-N 2-hexylcyclopentan-1-one Chemical compound CCCCCCC1CCCC1=O JTHVYOIHZNYRCC-UHFFFAOYSA-N 0.000 description 1
- RFVNOJDQRGSOEL-UHFFFAOYSA-N 2-hydroxyethyl octadecanoate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCCO RFVNOJDQRGSOEL-UHFFFAOYSA-N 0.000 description 1
- UPHOPMSGKZNELG-UHFFFAOYSA-N 2-hydroxynaphthalene-1-carboxylic acid Chemical compound C1=CC=C2C(C(=O)O)=C(O)C=CC2=C1 UPHOPMSGKZNELG-UHFFFAOYSA-N 0.000 description 1
- ZPVFWPFBNIEHGJ-UHFFFAOYSA-N 2-octanone Chemical compound CCCCCCC(C)=O ZPVFWPFBNIEHGJ-UHFFFAOYSA-N 0.000 description 1
- ILPBINAXDRFYPL-UHFFFAOYSA-N 2-octene Chemical compound CCCCCC=CC ILPBINAXDRFYPL-UHFFFAOYSA-N 0.000 description 1
- ILHZVKAXFCDFMT-UHFFFAOYSA-N 2-pentylcyclopent-2-en-1-one Chemical compound CCCCCC1=CCCC1=O ILHZVKAXFCDFMT-UHFFFAOYSA-N 0.000 description 1
- VNWOJVJCRAHBJJ-UHFFFAOYSA-N 2-pentylcyclopentan-1-one Chemical compound CCCCCC1CCCC1=O VNWOJVJCRAHBJJ-UHFFFAOYSA-N 0.000 description 1
- ZRYDPLOWJSFQAE-UHFFFAOYSA-N 2-tert-butylcyclohexan-1-one Chemical class CC(C)(C)C1CCCCC1=O ZRYDPLOWJSFQAE-UHFFFAOYSA-N 0.000 description 1
- JHHZQADGLDKIPM-AATRIKPKSA-N 3-Hepten-2-one Chemical compound CCC\C=C\C(C)=O JHHZQADGLDKIPM-AATRIKPKSA-N 0.000 description 1
- YCIXWYOBMVNGTB-UHFFFAOYSA-N 3-methyl-2-pentylcyclopent-2-en-1-one Chemical compound CCCCCC1=C(C)CCC1=O YCIXWYOBMVNGTB-UHFFFAOYSA-N 0.000 description 1
- XMIIGOLPHOKFCH-UHFFFAOYSA-N 3-phenylpropionic acid Chemical class OC(=O)CCC1=CC=CC=C1 XMIIGOLPHOKFCH-UHFFFAOYSA-N 0.000 description 1
- GNKZMNRKLCTJAY-UHFFFAOYSA-N 4'-Methylacetophenone Chemical compound CC(=O)C1=CC=C(C)C=C1 GNKZMNRKLCTJAY-UHFFFAOYSA-N 0.000 description 1
- DCSKAMGZSIRJAQ-UHFFFAOYSA-N 4-(2-methylbutan-2-yl)cyclohexan-1-one Chemical compound CCC(C)(C)C1CCC(=O)CC1 DCSKAMGZSIRJAQ-UHFFFAOYSA-N 0.000 description 1
- PCBSXBYCASFXTM-UHFFFAOYSA-N 4-(4-Methoxyphenyl)-2-butanone Chemical compound COC1=CC=C(CCC(C)=O)C=C1 PCBSXBYCASFXTM-UHFFFAOYSA-N 0.000 description 1
- CYDQOEWLBCCFJZ-UHFFFAOYSA-N 4-(4-fluorophenyl)oxane-4-carboxylic acid Chemical compound C=1C=C(F)C=CC=1C1(C(=O)O)CCOCC1 CYDQOEWLBCCFJZ-UHFFFAOYSA-N 0.000 description 1
- OAFJAALOFJVHMK-UHFFFAOYSA-N 4-cyclohexyl-4-methylpentan-2-one Chemical compound CC(=O)CC(C)(C)C1CCCCC1 OAFJAALOFJVHMK-UHFFFAOYSA-N 0.000 description 1
- NTPLXRHDUXRPNE-UHFFFAOYSA-N 4-methoxyacetophenone Chemical compound COC1=CC=C(C(C)=O)C=C1 NTPLXRHDUXRPNE-UHFFFAOYSA-N 0.000 description 1
- CCCIYAQYQZQDIZ-UHFFFAOYSA-N 6-methylheptan-3-one Chemical compound CCC(=O)CCC(C)C CCCIYAQYQZQDIZ-UHFFFAOYSA-N 0.000 description 1
- HBAQYPYDRFILMT-UHFFFAOYSA-N 8-[3-(1-cyclopropylpyrazol-4-yl)-1H-pyrazolo[4,3-d]pyrimidin-5-yl]-3-methyl-3,8-diazabicyclo[3.2.1]octan-2-one Chemical class C1(CC1)N1N=CC(=C1)C1=NNC2=C1N=C(N=C2)N1C2C(N(CC1CC2)C)=O HBAQYPYDRFILMT-UHFFFAOYSA-N 0.000 description 1
- 235000007173 Abies balsamea Nutrition 0.000 description 1
- 201000004384 Alopecia Diseases 0.000 description 1
- VHUUQVKOLVNVRT-UHFFFAOYSA-N Ammonium hydroxide Chemical compound [NH4+].[OH-] VHUUQVKOLVNVRT-UHFFFAOYSA-N 0.000 description 1
- 235000014469 Bacillus subtilis Nutrition 0.000 description 1
- 239000004857 Balsam Substances 0.000 description 1
- TXVGPWFMICFNDH-UHFFFAOYSA-N C(C1=CC=CC=C1)CC(C)=O.COC1=CC=CC=C1 Chemical compound C(C1=CC=CC=C1)CC(C)=O.COC1=CC=CC=C1 TXVGPWFMICFNDH-UHFFFAOYSA-N 0.000 description 1
- COTNUBDHGSIOTA-RVWRRERJSA-N C(O)([2H])([2H])[2H].C(O)([2H])([2H])[2H] Chemical compound C(O)([2H])([2H])[2H].C(O)([2H])([2H])[2H] COTNUBDHGSIOTA-RVWRRERJSA-N 0.000 description 1
- BFWWFJGFAIZYNV-UHFFFAOYSA-N C1(=CC=CC=C1)C1OC2=CC=CC=C2CC1.O1C(CCC2=CC=CC=C12)C1=CC=CC=C1 Chemical compound C1(=CC=CC=C1)C1OC2=CC=CC=C2CC1.O1C(CCC2=CC=CC=C12)C1=CC=CC=C1 BFWWFJGFAIZYNV-UHFFFAOYSA-N 0.000 description 1
- YDNKGFDKKRUKPY-JHOUSYSJSA-N C16 ceramide Natural products CCCCCCCCCCCCCCCC(=O)N[C@@H](CO)[C@H](O)C=CCCCCCCCCCCCCC YDNKGFDKKRUKPY-JHOUSYSJSA-N 0.000 description 1
- UXVMQQNJUSDDNG-UHFFFAOYSA-L Calcium chloride Chemical compound [Cl-].[Cl-].[Ca+2] UXVMQQNJUSDDNG-UHFFFAOYSA-L 0.000 description 1
- WBYWAXJHAXSJNI-SREVYHEPSA-N Cinnamic acid Chemical compound OC(=O)\C=C/C1=CC=CC=C1 WBYWAXJHAXSJNI-SREVYHEPSA-N 0.000 description 1
- 241000195493 Cryptophyta Species 0.000 description 1
- 229920000832 Cutin Polymers 0.000 description 1
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 1
- YPZMPEPLWKRVLD-PJEQPVAWSA-N D-Glycero-D-gulo-Heptose Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)[C@@H](O)C=O YPZMPEPLWKRVLD-PJEQPVAWSA-N 0.000 description 1
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 description 1
- RGHNJXZEOKUKBD-UHFFFAOYSA-N D-gluconic acid Natural products OCC(O)C(O)C(O)C(O)C(O)=O RGHNJXZEOKUKBD-UHFFFAOYSA-N 0.000 description 1
- 206010013786 Dry skin Diseases 0.000 description 1
- 229920001875 Ebonite Polymers 0.000 description 1
- 239000004593 Epoxy Substances 0.000 description 1
- 208000035126 Facies Diseases 0.000 description 1
- 108010010803 Gelatin Proteins 0.000 description 1
- WHUUTDBJXJRKMK-UHFFFAOYSA-N Glutamic acid Natural products OC(=O)C(N)CCC(O)=O WHUUTDBJXJRKMK-UHFFFAOYSA-N 0.000 description 1
- 235000001453 Glycyrrhiza echinata Nutrition 0.000 description 1
- 244000303040 Glycyrrhiza glabra Species 0.000 description 1
- 235000006200 Glycyrrhiza glabra Nutrition 0.000 description 1
- 235000017382 Glycyrrhiza lepidota Nutrition 0.000 description 1
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 1
- 244000018716 Impatiens biflora Species 0.000 description 1
- XMLSXPIVAXONDL-PLNGDYQASA-N Jasmone Chemical compound CC\C=C/CC1=C(C)CCC1=O XMLSXPIVAXONDL-PLNGDYQASA-N 0.000 description 1
- WHUUTDBJXJRKMK-VKHMYHEASA-N L-glutamic acid Chemical compound OC(=O)[C@@H](N)CCC(O)=O WHUUTDBJXJRKMK-VKHMYHEASA-N 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- TXXHDPDFNKHHGW-CCAGOZQPSA-N Muconic acid Natural products OC(=O)\C=C/C=C\C(O)=O TXXHDPDFNKHHGW-CCAGOZQPSA-N 0.000 description 1
- 101100096342 Mus musculus Spdef gene Proteins 0.000 description 1
- CRJGESKKUOMBCT-VQTJNVASSA-N N-acetylsphinganine Chemical compound CCCCCCCCCCCCCCC[C@@H](O)[C@H](CO)NC(C)=O CRJGESKKUOMBCT-VQTJNVASSA-N 0.000 description 1
- GRYLNZFGIOXLOG-UHFFFAOYSA-N Nitric acid Chemical compound O[N+]([O-])=O GRYLNZFGIOXLOG-UHFFFAOYSA-N 0.000 description 1
- IYTXKIXETAELAV-UHFFFAOYSA-N Nonan-3-one Chemical class CCCCCCC(=O)CC IYTXKIXETAELAV-UHFFFAOYSA-N 0.000 description 1
- 229920002230 Pectic acid Polymers 0.000 description 1
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N Phenol Chemical class OC1=CC=CC=C1 ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 1
- 239000002202 Polyethylene glycol Substances 0.000 description 1
- 239000004372 Polyvinyl alcohol Substances 0.000 description 1
- 241000219000 Populus Species 0.000 description 1
- IWYDHOAUDWTVEP-UHFFFAOYSA-N R-2-phenyl-2-hydroxyacetic acid Natural products OC(=O)C(O)C1=CC=CC=C1 IWYDHOAUDWTVEP-UHFFFAOYSA-N 0.000 description 1
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 1
- 235000021355 Stearic acid Nutrition 0.000 description 1
- KDYFGRWQOYBRFD-UHFFFAOYSA-N Succinic acid Natural products OC(=O)CCC(O)=O KDYFGRWQOYBRFD-UHFFFAOYSA-N 0.000 description 1
- BHEOSNUKNHRBNM-UHFFFAOYSA-N Tetramethylsqualene Natural products CC(=C)C(C)CCC(=C)C(C)CCC(C)=CCCC=C(C)CCC(C)C(=C)CCC(C)C(C)=C BHEOSNUKNHRBNM-UHFFFAOYSA-N 0.000 description 1
- 235000006468 Thea sinensis Nutrition 0.000 description 1
- 240000001519 Verbena officinalis Species 0.000 description 1
- 235000018718 Verbena officinalis Nutrition 0.000 description 1
- 150000007513 acids Chemical class 0.000 description 1
- 125000002252 acyl group Chemical group 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 230000000996 additive effect Effects 0.000 description 1
- 239000000443 aerosol Substances 0.000 description 1
- 239000000809 air pollutant Substances 0.000 description 1
- 231100001243 air pollutant Toxicity 0.000 description 1
- 235000013334 alcoholic beverage Nutrition 0.000 description 1
- 239000000783 alginic acid Substances 0.000 description 1
- 235000010443 alginic acid Nutrition 0.000 description 1
- 229920000615 alginic acid Polymers 0.000 description 1
- 229960001126 alginic acid Drugs 0.000 description 1
- 150000004781 alginic acids Chemical class 0.000 description 1
- 239000003513 alkali Substances 0.000 description 1
- 125000000217 alkyl group Chemical group 0.000 description 1
- 230000000172 allergic effect Effects 0.000 description 1
- 230000003281 allosteric effect Effects 0.000 description 1
- BJEPYKJPYRNKOW-UHFFFAOYSA-N alpha-hydroxysuccinic acid Natural products OC(=O)C(O)CC(O)=O BJEPYKJPYRNKOW-UHFFFAOYSA-N 0.000 description 1
- JZQOJFLIJNRDHK-CMDGGOBGSA-N alpha-irone Chemical compound CC1CC=C(C)C(\C=C\C(C)=O)C1(C)C JZQOJFLIJNRDHK-CMDGGOBGSA-N 0.000 description 1
- 150000001412 amines Chemical class 0.000 description 1
- 239000000908 ammonium hydroxide Substances 0.000 description 1
- 230000001166 anti-perspirative effect Effects 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 230000003078 antioxidant effect Effects 0.000 description 1
- 235000006708 antioxidants Nutrition 0.000 description 1
- 239000003213 antiperspirant Substances 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 235000010323 ascorbic acid Nutrition 0.000 description 1
- 229960005070 ascorbic acid Drugs 0.000 description 1
- 239000011668 ascorbic acid Substances 0.000 description 1
- 239000012298 atmosphere Substances 0.000 description 1
- 208000010668 atopic eczema Diseases 0.000 description 1
- 235000013871 bee wax Nutrition 0.000 description 1
- 239000012166 beeswax Substances 0.000 description 1
- SRSXLGNVWSONIS-UHFFFAOYSA-N benzenesulfonic acid Chemical compound OS(=O)(=O)C1=CC=CC=C1 SRSXLGNVWSONIS-UHFFFAOYSA-N 0.000 description 1
- 229940092714 benzenesulfonic acid Drugs 0.000 description 1
- 229930008407 benzylideneacetone Natural products 0.000 description 1
- 235000015895 biscuits Nutrition 0.000 description 1
- 230000000903 blocking effect Effects 0.000 description 1
- SXDBWCPKPHAZSM-UHFFFAOYSA-N bromic acid Chemical compound OBr(=O)=O SXDBWCPKPHAZSM-UHFFFAOYSA-N 0.000 description 1
- KDYFGRWQOYBRFD-NUQCWPJISA-N butanedioic acid Chemical compound O[14C](=O)CC[14C](O)=O KDYFGRWQOYBRFD-NUQCWPJISA-N 0.000 description 1
- ADRVNXBAWSRFAJ-UHFFFAOYSA-N catechin Natural products OC1Cc2cc(O)cc(O)c2OC1c3ccc(O)c(O)c3 ADRVNXBAWSRFAJ-UHFFFAOYSA-N 0.000 description 1
- 235000005487 catechin Nutrition 0.000 description 1
- 238000005119 centrifugation Methods 0.000 description 1
- 229940106189 ceramide Drugs 0.000 description 1
- ZVEQCJWYRWKARO-UHFFFAOYSA-N ceramide Natural products CCCCCCCCCCCCCCC(O)C(=O)NC(CO)C(O)C=CCCC=C(C)CCCCCCCCC ZVEQCJWYRWKARO-UHFFFAOYSA-N 0.000 description 1
- 235000013351 cheese Nutrition 0.000 description 1
- 229940112822 chewing gum Drugs 0.000 description 1
- 235000015218 chewing gum Nutrition 0.000 description 1
- 235000019219 chocolate Nutrition 0.000 description 1
- 235000012000 cholesterol Nutrition 0.000 description 1
- 229950001002 cianidanol Drugs 0.000 description 1
- 229930016911 cinnamic acid Natural products 0.000 description 1
- 235000013985 cinnamic acid Nutrition 0.000 description 1
- IVLCENBZDYVJPA-ARJAWSKDSA-N cis-Jasmone Natural products C\C=C/CC1=C(C)CCC1=O IVLCENBZDYVJPA-ARJAWSKDSA-N 0.000 description 1
- HGCIXCUEYOPUTN-UHFFFAOYSA-N cis-cyclohexene Natural products C1CCC=CC1 HGCIXCUEYOPUTN-UHFFFAOYSA-N 0.000 description 1
- 229940069647 citric acid 1000 mg Drugs 0.000 description 1
- 235000020965 cold beverage Nutrition 0.000 description 1
- 239000000084 colloidal system Substances 0.000 description 1
- 239000012141 concentrate Substances 0.000 description 1
- 235000009508 confectionery Nutrition 0.000 description 1
- 239000002826 coolant Substances 0.000 description 1
- 230000006003 cornification Effects 0.000 description 1
- OILAIQUEIWYQPH-UHFFFAOYSA-N cyclohexane-1,2-dione Chemical class O=C1CCCCC1=O OILAIQUEIWYQPH-UHFFFAOYSA-N 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 239000008367 deionised water Substances 0.000 description 1
- 229910021641 deionized water Inorganic materials 0.000 description 1
- 239000003599 detergent Substances 0.000 description 1
- 230000004069 differentiation Effects 0.000 description 1
- 238000009792 diffusion process Methods 0.000 description 1
- PRAKJMSDJKAYCZ-UHFFFAOYSA-N dodecahydrosqualene Natural products CC(C)CCCC(C)CCCC(C)CCCCC(C)CCCC(C)CCCC(C)C PRAKJMSDJKAYCZ-UHFFFAOYSA-N 0.000 description 1
- MOTZDAYCYVMXPC-UHFFFAOYSA-N dodecyl hydrogen sulfate Chemical compound CCCCCCCCCCCCOS(O)(=O)=O MOTZDAYCYVMXPC-UHFFFAOYSA-N 0.000 description 1
- 229940043264 dodecyl sulfate Drugs 0.000 description 1
- 230000035622 drinking Effects 0.000 description 1
- 238000001647 drug administration Methods 0.000 description 1
- 230000000857 drug effect Effects 0.000 description 1
- 230000037336 dry skin Effects 0.000 description 1
- 239000003792 electrolyte Substances 0.000 description 1
- 239000003974 emollient agent Substances 0.000 description 1
- 239000000839 emulsion Substances 0.000 description 1
- 230000007613 environmental effect Effects 0.000 description 1
- CCIVGXIOQKPBKL-UHFFFAOYSA-M ethanesulfonate Chemical compound CCS([O-])(=O)=O CCIVGXIOQKPBKL-UHFFFAOYSA-M 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- LTUMRKDLVGQMJU-UHFFFAOYSA-N famesylacetone Natural products CC(C)=CCCC(C)=CCCC(C)=CCCC(C)=O LTUMRKDLVGQMJU-UHFFFAOYSA-N 0.000 description 1
- LTUMRKDLVGQMJU-IUBLYSDUSA-N farnesyl acetone Chemical compound CC(C)=CCC\C(C)=C\CC\C(C)=C\CCC(C)=O LTUMRKDLVGQMJU-IUBLYSDUSA-N 0.000 description 1
- 229930006735 fenchone Natural products 0.000 description 1
- 239000004503 fine granule Substances 0.000 description 1
- 235000015203 fruit juice Nutrition 0.000 description 1
- 239000001530 fumaric acid Substances 0.000 description 1
- 235000011087 fumaric acid Nutrition 0.000 description 1
- 230000000855 fungicidal effect Effects 0.000 description 1
- 239000000417 fungicide Substances 0.000 description 1
- 239000008273 gelatin Substances 0.000 description 1
- 229920000159 gelatin Polymers 0.000 description 1
- 235000019322 gelatine Nutrition 0.000 description 1
- 235000011852 gelatine desserts Nutrition 0.000 description 1
- HNZUNIKWNYHEJJ-FMIVXFBMSA-N geranyl acetone Chemical compound CC(C)=CCC\C(C)=C\CCC(C)=O HNZUNIKWNYHEJJ-FMIVXFBMSA-N 0.000 description 1
- 239000000174 gluconic acid Substances 0.000 description 1
- 235000012208 gluconic acid Nutrition 0.000 description 1
- 239000004220 glutamic acid Substances 0.000 description 1
- 235000013922 glutamic acid Nutrition 0.000 description 1
- YQEMORVAKMFKLG-UHFFFAOYSA-N glycerine monostearate Natural products CCCCCCCCCCCCCCCCCC(=O)OC(CO)CO YQEMORVAKMFKLG-UHFFFAOYSA-N 0.000 description 1
- SVUQHVRAGMNPLW-UHFFFAOYSA-N glycerol monostearate Natural products CCCCCCCCCCCCCCCCC(=O)OCC(O)CO SVUQHVRAGMNPLW-UHFFFAOYSA-N 0.000 description 1
- 229940094952 green tea extract Drugs 0.000 description 1
- 235000020688 green tea extract Nutrition 0.000 description 1
- 229940093915 gynecological organic acid Drugs 0.000 description 1
- JEGUKCSWCFPDGT-UHFFFAOYSA-N h2o hydrate Chemical compound O.O JEGUKCSWCFPDGT-UHFFFAOYSA-N 0.000 description 1
- 239000000118 hair dye Substances 0.000 description 1
- 230000003676 hair loss Effects 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 230000003862 health status Effects 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 230000036571 hydration Effects 0.000 description 1
- 238000006703 hydration reaction Methods 0.000 description 1
- 239000001257 hydrogen Substances 0.000 description 1
- 229910052739 hydrogen Inorganic materials 0.000 description 1
- 235000015243 ice cream Nutrition 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 239000001023 inorganic pigment Substances 0.000 description 1
- 229910017053 inorganic salt Inorganic materials 0.000 description 1
- 238000007918 intramuscular administration Methods 0.000 description 1
- 238000007912 intraperitoneal administration Methods 0.000 description 1
- 238000001990 intravenous administration Methods 0.000 description 1
- HJOVHMDZYOCNQW-UHFFFAOYSA-N isophorone Chemical compound CC1=CC(=O)CC(C)(C)C1 HJOVHMDZYOCNQW-UHFFFAOYSA-N 0.000 description 1
- 229940010454 licorice Drugs 0.000 description 1
- VZCYOOQTPOCHFL-UPHRSURJSA-N maleic acid Chemical compound OC(=O)\C=C/C(O)=O VZCYOOQTPOCHFL-UPHRSURJSA-N 0.000 description 1
- 239000011976 maleic acid Substances 0.000 description 1
- 239000001630 malic acid Substances 0.000 description 1
- 235000011090 malic acid Nutrition 0.000 description 1
- 229960002510 mandelic acid Drugs 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 229940098779 methanesulfonic acid Drugs 0.000 description 1
- WBYWAXJHAXSJNI-UHFFFAOYSA-N methyl p-hydroxycinnamate Natural products OC(=O)C=CC1=CC=CC=C1 WBYWAXJHAXSJNI-UHFFFAOYSA-N 0.000 description 1
- JPTOCTSNXXKSSN-UHFFFAOYSA-N methylheptenone Chemical compound CCCC=CC(=O)CC JPTOCTSNXXKSSN-UHFFFAOYSA-N 0.000 description 1
- 244000005700 microbiome Species 0.000 description 1
- 150000007522 mineralic acids Chemical class 0.000 description 1
- GQEZCXVZFLOKMC-UHFFFAOYSA-N n-alpha-hexadecene Natural products CCCCCCCCCCCCCCC=C GQEZCXVZFLOKMC-UHFFFAOYSA-N 0.000 description 1
- KVBGVZZKJNLNJU-UHFFFAOYSA-N naphthalene-2-sulfonic acid Chemical class C1=CC=CC2=CC(S(=O)(=O)O)=CC=C21 KVBGVZZKJNLNJU-UHFFFAOYSA-N 0.000 description 1
- VVGIYYKRAMHVLU-UHFFFAOYSA-N newbouldiamide Natural products CCCCCCCCCCCCCCCCCCCC(O)C(O)C(O)C(CO)NC(=O)CCCCCCCCCCCCCCCCC VVGIYYKRAMHVLU-UHFFFAOYSA-N 0.000 description 1
- 229910017604 nitric acid Inorganic materials 0.000 description 1
- YUPOCHDBBHTUBJ-UHFFFAOYSA-N nonadecan-10-one Chemical compound CCCCCCCCCC(=O)CCCCCCCCC YUPOCHDBBHTUBJ-UHFFFAOYSA-N 0.000 description 1
- VKCYHJWLYTUGCC-UHFFFAOYSA-N nonan-2-one Chemical compound CCCCCCCC(C)=O VKCYHJWLYTUGCC-UHFFFAOYSA-N 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 1
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 description 1
- 239000003605 opacifier Substances 0.000 description 1
- 229940126701 oral medication Drugs 0.000 description 1
- 235000005985 organic acids Nutrition 0.000 description 1
- 239000012860 organic pigment Substances 0.000 description 1
- 230000003204 osmotic effect Effects 0.000 description 1
- 238000007427 paired t-test Methods 0.000 description 1
- 239000006072 paste Substances 0.000 description 1
- LCLHHZYHLXDRQG-ZNKJPWOQSA-N pectic acid Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)O[C@H](C(O)=O)[C@@H]1OC1[C@H](O)[C@@H](O)[C@@H](OC2[C@@H]([C@@H](O)[C@@H](O)[C@H](O2)C(O)=O)O)[C@@H](C(O)=O)O1 LCLHHZYHLXDRQG-ZNKJPWOQSA-N 0.000 description 1
- 230000035515 penetration Effects 0.000 description 1
- RGSFGYAAUTVSQA-UHFFFAOYSA-N pentamethylene Natural products C1CCCC1 RGSFGYAAUTVSQA-UHFFFAOYSA-N 0.000 description 1
- TZMFJUDUGYTVRY-UHFFFAOYSA-N pentane-2,3-dione Chemical class CCC(=O)C(C)=O TZMFJUDUGYTVRY-UHFFFAOYSA-N 0.000 description 1
- 239000000546 pharmaceutical excipient Substances 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- 230000000704 physical effect Effects 0.000 description 1
- 230000001766 physiological effect Effects 0.000 description 1
- 230000035479 physiological effects, processes and functions Effects 0.000 description 1
- 229920001223 polyethylene glycol Polymers 0.000 description 1
- 239000010318 polygalacturonic acid Substances 0.000 description 1
- 238000006116 polymerization reaction Methods 0.000 description 1
- 229920001184 polypeptide Polymers 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- 150000004804 polysaccharides Chemical class 0.000 description 1
- 229920002451 polyvinyl alcohol Polymers 0.000 description 1
- 239000013641 positive control Substances 0.000 description 1
- 102000004196 processed proteins & peptides Human genes 0.000 description 1
- 108090000765 processed proteins & peptides Proteins 0.000 description 1
- KRIOVPPHQSLHCZ-UHFFFAOYSA-N propiophenone Chemical compound CCC(=O)C1=CC=CC=C1 KRIOVPPHQSLHCZ-UHFFFAOYSA-N 0.000 description 1
- 230000001681 protective effect Effects 0.000 description 1
- IUVKMZGDUIUOCP-BTNSXGMBSA-N quinbolone Chemical compound O([C@H]1CC[C@H]2[C@H]3[C@@H]([C@]4(C=CC(=O)C=C4CC3)C)CC[C@@]21C)C1=CCCC1 IUVKMZGDUIUOCP-BTNSXGMBSA-N 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 210000000664 rectum Anatomy 0.000 description 1
- 238000005057 refrigeration Methods 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 238000012827 research and development Methods 0.000 description 1
- 238000007789 sealing Methods 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 230000001568 sexual effect Effects 0.000 description 1
- 239000002453 shampoo Substances 0.000 description 1
- 238000010898 silica gel chromatography Methods 0.000 description 1
- 230000036555 skin type Effects 0.000 description 1
- 239000001509 sodium citrate Substances 0.000 description 1
- NLJMYIDDQXHKNR-UHFFFAOYSA-K sodium citrate Chemical compound O.O.[Na+].[Na+].[Na+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O NLJMYIDDQXHKNR-UHFFFAOYSA-K 0.000 description 1
- 239000001540 sodium lactate Substances 0.000 description 1
- 235000011088 sodium lactate Nutrition 0.000 description 1
- 229940005581 sodium lactate Drugs 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 239000000600 sorbitol Substances 0.000 description 1
- 150000003408 sphingolipids Chemical class 0.000 description 1
- 235000013599 spices Nutrition 0.000 description 1
- 229940031439 squalene Drugs 0.000 description 1
- TUHBEKDERLKLEC-UHFFFAOYSA-N squalene Natural products CC(=CCCC(=CCCC(=CCCC=C(/C)CCC=C(/C)CC=C(C)C)C)C)C TUHBEKDERLKLEC-UHFFFAOYSA-N 0.000 description 1
- 229910001220 stainless steel Inorganic materials 0.000 description 1
- 239000010935 stainless steel Substances 0.000 description 1
- 239000008117 stearic acid Substances 0.000 description 1
- 210000000434 stratum corneum Anatomy 0.000 description 1
- 238000007920 subcutaneous administration Methods 0.000 description 1
- 239000000829 suppository Substances 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 229960003080 taurine Drugs 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 239000002562 thickening agent Substances 0.000 description 1
- JOXIMZWYDAKGHI-UHFFFAOYSA-N toluene-4-sulfonic acid Chemical class CC1=CC=C(S(O)(=O)=O)C=C1 JOXIMZWYDAKGHI-UHFFFAOYSA-N 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- BWHOZHOGCMHOBV-BQYQJAHWSA-N trans-benzylideneacetone Chemical compound CC(=O)\C=C\C1=CC=CC=C1 BWHOZHOGCMHOBV-BQYQJAHWSA-N 0.000 description 1
- XMLSXPIVAXONDL-UHFFFAOYSA-N trans-jasmone Natural products CCC=CCC1=C(C)CCC1=O XMLSXPIVAXONDL-UHFFFAOYSA-N 0.000 description 1
- CYIFVRUOHKNECG-UHFFFAOYSA-N tridecan-2-one Chemical compound CCCCCCCCCCCC(C)=O CYIFVRUOHKNECG-UHFFFAOYSA-N 0.000 description 1
- RYFMWSXOAZQYPI-UHFFFAOYSA-K trisodium phosphate Chemical compound [Na+].[Na+].[Na+].[O-]P([O-])([O-])=O RYFMWSXOAZQYPI-UHFFFAOYSA-K 0.000 description 1
- 239000006097 ultraviolet radiation absorber Substances 0.000 description 1
- 235000013311 vegetables Nutrition 0.000 description 1
- 229940051923 vitamin E 15 mg Drugs 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/105—Plant extracts, their artificial duplicates or their derivatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
- A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
- A61K8/4973—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with oxygen as the only hetero atom
- A61K8/498—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with oxygen as the only hetero atom having 6-membered rings or their condensed derivatives, e.g. coumarin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
- A61K8/9783—Angiosperms [Magnoliophyta]
- A61K8/9789—Magnoliopsida [dicotyledons]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2200/00—Function of food ingredients
- A23V2200/30—Foods, ingredients or supplements having a functional effect on health
- A23V2200/318—Foods, ingredients or supplements having a functional effect on health having an effect on skin health and hair or coat
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2300/00—Processes
- A23V2300/18—Fractionation
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Mycology (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Food Science & Technology (AREA)
- Botany (AREA)
- Birds (AREA)
- Polymers & Plastics (AREA)
- Nutrition Science (AREA)
- Biotechnology (AREA)
- Dermatology (AREA)
- Pharmacology & Pharmacy (AREA)
- Microbiology (AREA)
- Medicinal Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- General Preparation And Processing Of Foods (AREA)
- Cosmetics (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
This specification relates in one aspect to include Hydra composition of the post-fermented tea ketone fraction as active ingredient, is on the other hand related to comprising from galloyl -3 3-O- that post-fermented tea ketone fraction detaches, 3 ', 5,5 ', 7- penta hydroxy group flavane (3-O-galloyl-3,3',5,5', 7-pentahydroxyflavan), the Hydra composition of its isomers, its acceptable salt, its prodrug, its hydrate or its solvate as active ingredient, this specification can be applied to and the relevant various fields such as skin moisture-keeping.
Description
Technical field
This specification is related to a kind of including 3-O- galloyls -3,3 ', 5,5 ', 7- penta hydroxy group flavane (3-O-galloyl-3,3',
5,5', 7-pentahydroxyflavan) Hydra composition.
Background technology
The skin of the mankind plays the barrier function from outer protection individual.Barrier function is for from external various thorns
Swash the defence of (chemical substance, Air Pollutants, the environment of drying, ultraviolet light etc.) and prevents internal water excessive by skin
The defencive function of diffusion, this defencive function is only in the case where the cuticula being made of keratinocyte is normally formed
It could maintain its function.It is present in outermost cuticula (Stratum corneum, horney layer) in epidermis by cutin
It forms the horn cell that cell forms, and terminated by differentiation and the lipid layer for surrounding the horn cell and constitutes (Mar celo
C.L.et al,J.Invest.Dermatol.,80,pp37-44,1983).Keratinocyte generates day in cornification processes
Right moisturizing factor (Natural moisturizing factor;) and intercellular lipid (ceramide, cholesterol, fat NMF
Acid), to form cuticula, make cuticula that there is robustness and flexibility, to play as skin barrier (skin
Barrier function).
This cuticula may pass through the atmosphere pollution of excessive living habits sexual factor or the drying such as wash one's face, have a bath
Its function is easy loss due to disease in the environmental factors such as matter and allergic skin or such as geroderma, actually arrives
The modern various factors due to further increasing complains dry skin symptom and the thus example of caused various interference recently
In the presence of the trend gradually increased.
In order to maintain moisture of skin appropriate, various are externally supplied moisture or moisture is prevented to be lost in from internal
Research, although actually exploitation have the various moisturizer (moisturizer) with water retention property, with to chemical substance
The concern of harmfulness improves, and the moisturizing ingredient exploitation necessity from natural materials gradually increases, but this from natural materials
Moisturizing ingredient research and development also deficiency be truth.
Invention content
The present invention is related to the moisturizing materials from natural materials on the one hand, is fractionated as a result, comprising post-fermented tea with providing
For the purpose of the Hydra composition of object.
The present invention is on the other hand to provide comprising the 3-O- galloyls -3,3 ' detached from post-fermented tea fraction, 5,5 ', 7-
Penta hydroxy group flavane (3-O-galloyl-3,3',5,5', 7-pentahydroxyf lavan) and Hydra group as active ingredient
For the purpose of conjunction object.
In order to solve the above problems, the present invention provides skin moisture-keeping composition on the one hand, containing galloyl -3 3-O-,
3 ', 5,5 ', 7- penta hydroxy group flavane (3-O-galloyl-3,3',5,5', 7-pentahydroxyflava n), its isomers, its
Acceptable salt, its prodrug, its hydrate, its solvate, comprising its post-fermented tea ketone fraction as active ingredient.
The present invention provides skin moisturization process on the other hand, wherein including:By 3-O- galloyls -3,3 ', 5,5 ', 7- five
Hydroxyl flavane (3-O-galloyl-3,3',5,5', 7-pentahydroxyflavan), its isomers, its acceptable salt, its
Prodrug, its hydrate, its solvate or comprising its post-fermented tea ketone fraction as active ingredient to individual carry out to
Medicine.
The present invention provides the 3-O- galloyls -3,3 ' of the manufacture for skin moisture-keeping composition, 5,5 ', 7- on the other hand
Penta hydroxy group flavane (3-O-galloyl-3,3',5,5', 7-pentahydroxyflavan), its isomers, its acceptable salt,
The purposes of its prodrug, its hydrate, its solvate or the post-fermented tea ketone fraction comprising it.
The present invention on the other hand, as the active ingredient for skin moisture-keeping, provides galloyl -3 3-O-, and 3 ', 5,5 ', 7-
Penta hydroxy group flavane (3-O-galloyl-3,3',5,5', 7-pentahydroxyflavan), its isomers, its acceptable salt,
Its prodrug, its hydrate, its solvate or the post-fermented tea ketone fraction comprising it.
In addition, the present invention on the other hand, provides galloyl -3 3-O- as the active ingredient for skin moisture-keeping, 3 ',
5,5 ', 7- penta hydroxy group flavane (3-O-galloyl-3,3',5,5', 7-pentahydroxyflavan), its isomers, it can connect
The non-therapeutic cosmetic of the salt, its prodrug, its hydrate, its solvate or the post-fermented tea ketone fraction comprising it received
On the way.
The present invention provides the composition comprising post-fermented tea ketone fraction and the combination comprising specific compound on the one hand
Object, so as to be widely used in moisturizing related field.
Description of the drawings
Fig. 1 be with high performance liquid chromatography to post-fermented tea extract analyzed as a result, indicating to be fractionated by acetone
Situation and the case where be fractionated without acetone.
Fig. 2 indicates to utilize high capacity highly effective adverse current chromatogram (high-performance countercurrent
Chromatography, HPCCC) chloroform of caffeine will be eliminated:Methanol 10:1 (v/v) fraction is divided into 10 sub- fractions.
Fig. 3 indicates the fraction 1 to 5 in the above-mentioned 10 sub- fractions using HPCCC fractionation.
Fig. 4 indicates the fraction 6 to 10 in the above-mentioned 10 sub- fractions using HPCCC fractionation.
Fig. 5 indicates trans- -3-O- galloyls -3,3 ', nuclear magnetic resonance (NMR) chart of 5,5 ', 7- penta hydroxy group flavane.
Specific implementation mode
In the following, being described in detail to this specification.
In this specification, " post-fermented tea " include using the other microorganisms or substance for being not present in enzyme in tealeaves into
The tea of row fermentation.
In this specification, " ketone fraction " includes object obtained by being fractionated to predetermined substance or extract using ketone solvent
Remaining substance after matter or fractionation, also comprising substance obtained by extracting these again with specific solvent.The type of above-mentioned ketone can
To be any type, but preferably acetone, arbitrary side that fractional method and extracting method can be known to the skilled person
Method.
In this specification, " isomers " includes not only especially optical isomer (optical isomers) (for example, base
Pure mirror image isomer (essentially pure enantiomers), substantially pure partial stereoisomer in sheet
(essentially pure diastereomers) or their mixture), also include rotamer (conformation
Isomers) (that is, isomers that more than one chemical bond only has its angle different), position isomer (position
Isomers) (especially tautomer (tautomers)) or geometric isomer (geometric isomers) are (for example, suitable
Formula-transisomer).
In this specification, " substantially pure (essentially pure) " refers to for example about mirror image isomer or part
In the case that isomers carries out use, the particular compound that can be used as mirror image isomer or partial allosteric body and enumerate exists about
90% or more, preferably from about 95% or more, even more preferably about 97% or more or about 98% or more, more preferably about 99% with
On, still more preferably it is about 99.5% or more (w/w).
In this specification, " acceptable " refers to when being utilized with usual or medicine and pharmacology usage amount (dosage), by avoiding
Comparable toxic effect can be used in animal, and the supervision that can obtain government or its approval in the mankind more specifically can be used
The approval of mechanism has got the Green Light, or is identified as Codex Alimentarius (Food code), healthy function Codex Alimentarius or one
As pharmacopeia in enumerate or be recorded in situation in other general literatures.
In this specification, " acceptable salt " refers to usual or pharmaceutically acceptable and has certain compound (parent
Compound the salt according to an aspect of the present invention of preferred pharmacological activity).Above-mentioned salt can include (1) by such as hydrochloric acid, hydrogen
The inorganic acids such as bromic acid, sulfuric acid, nitric acid, phosphoric acid are formed;Or by such as acetic acid, propionic acid, caproic acid, pentamethylene propionic acid, glycolic, acetone
Acid, lactic acid, malonic acid, succinic acid, malic acid, maleic acid, fumaric acid, tartaric acid, citric acid, benzoic acid, 3- (4- hydroxy benzenes first
Acyl group) benzoic acid, cinnamic acid, mandelic acid, methanesulfonic acid, ethanesulfonic acid, 1,2- ethionic acids, 2- isethionic acids, benzene sulfonic acid, 4- chlorine
Benzene sulfonic acid, 2- naphthalene sulfonic acids, 4- toluenesulfonic acids, camphorsulfonic acid, 4- Jia Jishuanhuans [2,2,2]Oct-2-ene -1- carboxylic acids, glucoheptose
Acid, 3- phenylpropionic acids, trimethylace tonitric, butylacetic acid, lauryl sulfate, gluconic acid, glutamic acid, hydroxynaphthoic acid, water
The acid-addition salts (acid addition salt) that the organic acids such as poplar acid, stearic acid, muconic acid are formed;Or (2) are present in mother
The salt that acid proton in body compound is formed when substituted.
In this specification, " prodrug (prodrug) " is to instigate certain substance that chemical change occurs and adjust physical property, change
The drug for learning property can pass through chemistry, physiology or enzyme in vivo although itself will not show physiological activity after administration
Effect and become original drug to play drug effect.
In this specification, " hydrate (hydrate) " refers to the compound for being combined with water, is comprising between water and compound
There is no the extensive concept of the interior packet compound of chemical binding force.
In this specification, " solvate " refer to solute molecule or ion and the molecule or ion of solvent between generate
High-orderCompound.
An aspect of of the present present invention provides a kind of Hydra composition, and it includes the 3-O- galloyls-indicated by following chemical formula 1
3,3 ', 5,5 ', 7- penta hydroxy group flavane (3-O-galloyl-3,3',5,5', 7-pentahydroxyfla van), its isomers,
Its acceptable salt, its pharmaceutically acceptable salt, its prodrug, its hydrate, its solvate or the post-fermented tea comprising it
Ketone fraction is as active ingredient.Above-mentioned moisturizing includes skin moisture-keeping.
[Chemical formula 1]
According to a concrete example, above-mentioned post-fermented tea ketone fraction can be the water-insoluble extract for post-fermented tea
Ketone fraction.
According to another concrete example, above-mentioned galloyl -3 3-O-, 3 ', 5,5 ', 7- penta hydroxy groups flavane can be by following chemical formula 2
Trans- -3-O- the galloyls -3,3 ' indicated, 5,5 ', 7- penta hydroxy group flavane (Trans-3-O-galloyl-3,3',5,5',7-
pentahydroxyflavan)." flavane (flavan) " in this specification indicates above-mentioned 3-O- galloyls -3,3 ', 5,5 ', 7- five
Hydroxyl flavane or trans- -3-O- galloyls -3,3 ', 5,5 ', 7- penta hydroxy group flavane.
[Chemical formula 2]
According to another concrete example, above-mentioned ketone fraction can be the alcohol extracting thing of ketone fraction.
According to another concrete example, above-mentioned ketone can include acetone, carvol (carvon), pulegone (pulegone),
Isolongitolanone (isolongifolanone), 2-HEPTANONE, 2 pentanone, 3- cyclohexanone, 3- heptanone, 4- heptanone, methyln-hexyl ketone, 3- are pungent
Ketone, methyl n-heptyl ketone, 3- nonanones, methyln nonyl ketone, methyl n-undecyl ketone, methyl isopropyl Ketone, ethyl isoamyl ketone, butylideneacetone,
Methyl heptenone, dimethyl-octa ketenes, geranyl acetone, farnesyl acetone, 2,3- pentanediones, 2,3- cyclohexanediones, 3,4-
Acetyl butyryl, 2,3- heptadione, amyl cyclopentanone, amyl cyclopentenone, 2- cyclopenta rings pentanone, hexyl cyclopentanone, 2- n-heptyls
Cyclopentanone, cis-jasmone, dihydro jasmone, methyl cyclopentenyl ketone2- tert-butyl cyclohexanones,
Para-tertiary butyl cyclohexanone, 2- sec-butyl cyclohexanones, apione, cryptone, orivone, 1- (3,5,6- trimethyls -3-
Cyclohexene -1- bases) ethyl ketone, nerone, 4- cyclohexyl -4-methyl-2 pentanone, oxydone, epoxy
IsophoroneMethyl naphthyl ketone, Alpha-Methyl anisal acetone, Anisylacetone, to methoxybenzene
Benzylacetone, BENZYLIDENE ACETONE, acetanisole, melilotal, propiophenone, acetophenone, α-imperial court's ketone
(Dynascone), iritone (lritone), ionone (ionone), pseudoionone (Pseudoionone), irone,
Methyl iritone, 2,4- di-t-butyls cyclohexanone, allyl ionone, 2- acetyl group -3,3- dimethyl norbornane, Verbena officinalis
Ketenes, fenchone (fenchon), cyclopentadecanone, ring hexadecene ketone etc. can include that all can usually make as in the field
The mixture of the ketone of solvent and they can be preferably acetone.
According to another concrete example, above-mentioned alcohol can be the independent alcohol or mixture that can usually use in this field, can be with
Preferably ethyl alcohol.
According to another concrete example, galloyl -3 3-O- in above-mentioned composition, 3 ', 5,5 ', 7- penta hydroxy groups flavane or trans- -3-
O- galloyls -3,3 ', 5,5 ', 7- penta hydroxy groups flavane, its isomers, its acceptable salt, its pharmaceutically acceptable salt, before it
Medicine, its hydrate or its solvate on the basis of above-mentioned composition total weight can be 0.000001 weight % or more,
0.000005 weight % or more, 0.00001 weight % or more, 0.00005 weight % or more, 0.0001 weight % or more,
0.0002 weight % or more, 0.0005 weight % or more, 0.001 weight % or more, 0.005 weight % or more, 0.01 weight %
Above, 0.05 weight % or more, 0.1 weight % or more, 0.3 weight % or more, 0.5 weight % or more, 1 weight % or more, 1.5
Weight % or more, 1.8 weight % or more, 2 weight % or more, 2.2 weight % or more, 2.5 weight % or more, 2.8 weight % with
Upper, 3 weight % or more, 3.2 weight % or more, 3.5 weight % or more, 3.8 weight % or more, 4 weight % or more, 4.2 weights
Measure % or more, 4.5 weight % or more or 4.8 weight % or more or 5 weight % or less, 4.8 weight % or less, 4.5 weights
Measure % or less, 4.2 weight % or less, 3.8 weight % or less, 3.5 weight % or less, 3.2 weight % or less, 3 weight % or less,
2.8 weight % or less, 2.5 weight % or less, 2.2 weight % or less, 2 weight % or less, 1.8 weight % or less, 1.5 weight %
Below, 1.2 weight % or less, 1 weight % or less, 0.5 weight % or less, 0.3 weight % or less, 0.1 weight % or less, 0.05
Weight % or less, 0.01 weight % or less, 0.005 weight % or less, 0.001 weight % or less, 0.0005 weight % or less,
0.0002 weight % or less, 0.0001 weight % or less, 0.00005 weight % or less, 0.00001 weight % or less or
0.000005 weight % or less.Can be preferably 0.000001 to 5 weight %.
According to another concrete example, in above-mentioned composition, the content of post-fermented tea ketone fraction is relative to above-mentioned composition
Total weight can be 0.01 weight % or more, 0.1 weight % or more, 1 weight % or more, 5 weight % or more, 10 weight % with
Upper, 15 weight % or more, 20 weight % or more, 25 weight % or more, 30 weight % or more, 35 weight % or more, 40 weight %
Above, 45 weight % or more, 50 weight % or more, 55 weight % or more, 60 weight % or more, 65 weight % or more, 70 weights
% or more, 75 weight % or more, 80 weight % or more, 85 weight % or more, 90 weight % or more or 95 weight % or more are measured,
Or 100 below weight %, 95 weight % or less, 90 weight % or less, 85 weight % or less, 80 weight % or less, 75 weights
Measure % or less, 70 weight % or less, 65 weight % or less, 60 weight % or less, 55 weight % or less, 50 weight % or less, 45
Weight % or less, 40 weight % or less, 35 weight % or less, 30 weight % or less, 25 weight % or less, 20 weight % or less,
15 weight % or less, 10 weight % or less, 5 weight % or less, 1 weight % or less, 0.1 weight % or less or 0.05 weight %
Below.Can be preferably 0.01 weight % to 100 weight %.
According to another concrete example, in above-mentioned fraction, galloyl -3 3-O-, 3 ', 5,5 ', 7- penta hydroxy groups flavane or trans- -
3-O- galloyls -3,3 ', 5,5 ', 7- penta hydroxy groups flavane, its isomers, its acceptable salt, its pharmaceutically acceptable salt, before it
Medicine, its hydrate or its solvate can be 0.0001 weight % or more, 0.0002 weight on the basis of fraction total weight
Measure % or more, 0.0005 weight % or more, 0.001 weight % or more, 0.005 weight % or more, 0.01 weight % or more, 0.05
Weight % or more, 0.1 weight % or more, 0.5 weight % or more, 1 weight % or more, 1.5 weight % or more, 2 weight % or more,
2.5 weight % or more, 3 weight % or more, 3.5 weight % or more, 4 weight % or more or 4.5 weight % or more or 5 weights
Measure % or less, 4.5 weight % or less, 4 weight % or less, 3.5 weight % or less, 3 weight % or less, 2.5 weight % or less, 2
Weight % or less, 1.5 weight % or less, 1 weight % or less, 0.5 weight % or less, 0.1 weight % or less, 0.05 weight % with
Under, 0.01 weight % or less, 0.005 weight % or less, 0.001 weight % or less, 0.0005 weight % or less or 0.0002 weight
Measure % or less.0.0001 weight % can be preferably comprised to 5 weight %.
According to another concrete example, above-mentioned galloyl-3 3-O-, 3 ', 5,5 ', 7- penta hydroxy groups flavane or trans- galloyl-3-3-O-,
3 ', 5,5 ', 7- penta hydroxy group flavane, its isomers, its acceptable salt, its pharmaceutically acceptable salt, its prodrug, its hydration
The dosage of object or its solvate can be 0.0001g/kg/ days or more, 0.001g/kg/ days or more, 0.01g/kg/ days with
Upper, 0.1g/kg/ days or more, 1g/kg/ days or more, 2g/kg/ days or more, 3g/kg/ days or more, 4g/kg/ days or more, 5g/kg/
Its above, 6g/kg/ days or more, 7g/kg/ days or more, 8g/kg/ days or more, 9g/kg/ days or more, 10g/kg/ days or more, 11g/
Kg/ days or more, 12g/kg/ days or more, 13g/kg/ days or more or 14g/kg/ days or more or 15g/kg/ days or less, 14g/
Kg/ days or less, 13g/kg/ days or less, 12g/kg/ days or less, 11g/kg/ days or less, 10g/kg/ days or less, 9g/kg/ days with
Under, 8g/kg/ days or less, 7g/kg/ days or less, 6g/kg/ days or less, 5g/kg/ days or less, 4g/kg/ days or less, 3g/kg/ days
Below, 2g/kg/ days or less, 1g/kg/ days or less, 0.1g/kg/ days or less, 0.01g/kg/ days or less, 0.001g/kg/ days with
Under or 0.0005g/kg/ days or less days.It can be preferably 0.0001g/kg/ days to 15mg/kg/ days.
According to another concrete example, above-mentioned moisturizing can be to supply and prevent any one in moisture loss based on moisturizing
Kind or more.
An embodiment according to the present invention, using above-mentioned galloyl -3 3-O-, 3 ', 5,5 ', 7- penta hydroxy group flavane implements moisturizing
Experiment as a result, when by galloyl -3 3-O- of the present invention, 3 ', 5, when 5 ', 7- penta hydroxy group flavane is coated on skin, can define true
Recognize moisture of skin amount to dramatically increase (with reference to table 1), it can thus be appreciated that above-mentioned substance plays excellent moisturizing power.
Above-mentioned composition according to an aspect of the present invention can be pharmaceutical composition.Aforementioned pharmaceutical compositions can pass through
Oral, non-oral, rectum, local, transdermal, intravenous, intramuscular, intraperitoneal, subcutaneous etc. are administered.For oral medication
Dosage form can be tablet, pill, soft and hard rubber wafer, granule, powder, fine granule, liquor, opacifiers or micropill preparation,
But not limited to this.Dosage form for non-oral administration can be solution, suspending agent, emulsion agent, gel, injection, point
Drops, suppository, patch, ointment or spray, but not limited to this.Above-mentioned dosage form can be according to the common side in the field
Method is easily manufactured, can also include surfactant, excipient, hydrating agents, emulsification promoter, suspending agent, for adjust ooze
Salt or buffer, colorant, spice, stabilizer, preservative, preservative agent or the other common auxiliary agents pressed thoroughly.
The dosage of above-mentioned composition according to an aspect of the present invention or dosage according to age of the object being administered,
Gender, weight, pathological state and its seriousness, administration route or the judgement of prescriber and it is different.It is suitable based on this factor
The determination of dosage is in the level of those skilled in the art, one day administration dosage of active ingredient, such as can be 0.001 μ g/
Kg/ days to 5000mg/kg/ days, can be 0.0001mg/kg/ days to 15mg/kg/ days, but be not limited to more specifically
This.
According to another concrete example, above-mentioned composition can be food compositions or health food composition.
The dosage form of above-mentioned food compositions or health food composition is not particularly limited, for example, can be made tablet,
The dosage forms such as the liquors such as granula, pill, powder agent, capsule, potus, caramel, gel, stick, tea bag.Those skilled in the art can be with
According to dosage form or use purpose, without difficulty in the food compositions or health food composition of each dosage form in addition to effective
Usually used ingredient is suitably selected and is coordinated in the field other than ingredient, the case where being applied simultaneously with other raw materials
Under, it may occur however that synergy.
Above-mentioned composition can by simply absorbing, drinking, drug administration by injection, spray delivery or squeeze administration etc. various methods
It is administered.
In food compositions or health food composition according to an aspect of the present invention, the dosage of above-mentioned active ingredient
It determines in the level of those skilled in the art, dosage, which is administered, for example in one day to be 0.0001mg/kg/ days to 15mg/kg/
It, but not limited to this, can be different according to various factors such as the age of object to be administered, health status, complication.
Food compositions according to an aspect of the present invention or health food composition, such as can be chewing gum, caramel
The various foodstuffs such as product, confectionery, ice cream class, Biscuits can also be the beverages systems such as cold drink, mineral water, alcoholic beverage
Product include the healthy food class of vitamin or minerals etc..
In addition to the foregoing, according to an aspect of the present invention food compositions or health food composition can include each
The fragrance such as kind of nutritional agents, vitamin, minerals (electrolyte), synthetic perfume and natural perfume material, colorant and thickener (cheese,
Chocolate etc.), pectic acid and its salt, alginic acid and its salt, organic acid, protective colloid tackifier, pH adjusting agent, stabilizer,
Preservative, glycerine, alcohol, the carbonating agent etc. for soda.In addition to this, Combined food according to an aspect of the present invention
Object can also include for manufacturing fruit juice, fruit drink and the pulp of vegetable beverage.This ingredient can be alone or in combination
It uses.Although the ratio of this additive is not critically important, under normal circumstances, according to the present invention the one of every 100 parts by weight
The composition of aspect includes in the range of 0 to about 50 parts by weight.
According to another concrete example, above-mentioned composition can be Dermatologic preparation composition.Dermatologic preparation composition can be with
For the composition in cosmetics, oral agents, detergent, medicine and pharmacy etc., but not limited to this.Above-mentioned skin preparations for extenal use
Dosage form is not particularly limited, such as smoothing toner, firming lotion, alimentary water, nourishing cream, massage cream, essence, eye cream, eye can be made
The cosmetics such as portion's essence, make-up remover, makeup removing foam, makeup remover, facial mask, powder, body lotion, skin cream, soothing oil and U.S. flesh essence.
In addition, the Dermatologic preparation composition of this specification can also include selected from functional salt for special purpose
(salt) and one or more of the pH adjusting agent for adjusting pH.At this moment, above-mentioned salt can be selected from for ion shielding, protect
Inorganic salts, organic salt and/or the organic-inorganic salt of wet, ultraviolet light blocking etc..Concrete example, above-mentioned salt can be selected from sodium chloride
(NaCl), sodium phosphate (Na3PO4) and calcium chloride (CaCl2) etc..Above-mentioned pH adjusting agent is selected from sour (aicd) or alkali (base), such as
Hydrochloric acid, sulfuric acid, tartaric acid, citric acid, phosphoric acid, acetic acid, lactic acid, sodium lactate, sodium hydroxide, potassium hydroxide, alkyl can be selected from
Amine, alkanolamine and ammonium hydroxide etc..
The Dermatologic preparation composition of this specification can be cosmetics, pharmaceutically or medical exterior-applied article composition.It is above-mentioned
Cosmetics, pharmaceutically or medical exterior-applied article composition can also contain preservative, stabilizer, hydrating agents or emulsification promoter, use
In substance useful on the auxiliary agents such as the salt and/or buffer for adjusting osmotic pressure and other treatments.Breast can be made in above-mentioned composition
The dosage forms such as liquid, frost, ointment or gel.The above-mentioned preferred cutaneous penetration of Dermatologic preparation composition.
It is above-mentioned pharmaceutically or the dosage of the active ingredient of medical exterior-applied article composition is according to year of the object for receiving treatment
Age, gender, weight, specified disease to be treated or pathological state, the severity of disease or pathological state, administration route and prescription
The judgement of doctor and it is different.Dosage based on this factor is determined within the level of those skilled in the art.Usually
In the case of, the dosage of above-mentioned active ingredient can be in 0.0001mg/kg/ days to 15mg/kg/ days ranges, but are not limited to
This.
In the one side of this specification, composition is not particularly limited in terms of dosage form, can be cosmetic composition.
Above-mentioned cosmetic composition is used as such as skin and/or hair hair composition, such as can be smoothing toner, firming lotion, nourishing
Water, nourishing cream, massage cream, eye cream, eye essence, essence, make-up remover, makeup removing breast, makeup removing foam, makeup remover, facial mask, powder, body
Body breast, skin cream, U.S. flesh essence, shower cream, hair dye, shampoo, hair conditioner, hair styling agent, preparation for baldness, ointment, gel,
The dosage forms such as frost, patch, spray and adhering skin type, but not limited to this.
In addition, those skilled in the art can be according to the type of other external preparations or using purpose, without difficulty to each
Other ingredients in a dosage form other than above-mentioned required ingredient properly select and coordinate.
Can be cosmetic composition according to the above-mentioned composition of this specification, above-mentioned cosmetic composition can be to be suitble to
Locally applicable whole dosage forms provide.For example, lotion obtained from water phase can be scattered in solution, by oil phase, divide water phase
Dissipate lotion, suspension, solid, gel, powder, paste, micropin, foam (foam) or aerosol composition obtained from oil phase
Dosage form.The composition of this dosage form can be manufactured according to the conventional method in the field.
It, can be with other than the compound of this specification or fraction according in the cosmetic composition of this specification
Including the ingredient that functional additive and general cosmetic composition are included.As above-mentioned functional additive, can wrap
Containing the ingredient in water soluble vitamin, fat soluble vitamin, pdef polypeptide, polymerization polysaccharide, sphingolipid and marine algae extract.According to
For the cosmetic composition of this specification in the range of not influencing its main effect, can preferably comprise can be to main effect band
Carry out other ingredients of synergy.In addition, according to the cosmetic composition of this specification can also include moisturizer, emollient,
Surfactant, ultra-violet absorber, preservative, fungicide, antioxidant, pH adjusting agent, organic and inorganic pigment, fragrance,
Cooling agent or antiperspirant.The use level of mentioned component is not in the range of influencing the purpose and effect of this specification, this field skill
Art personnel can be readily selected, and use level can be 0.001 to 10 weight % on the basis of composition total weight, specifically
Can be 0.01 to 3 weight %.
The composition and effect of this specification are more specifically illustrated in the following, enumerating embodiment, experimental example and dosage form example.
But these examples only with help understand this specification illustration purpose and be provided, the scope of this specification and
Range is not limited to following examples.
<Embodiment 1>The manufacture of post-fermented tea sample
Water is added in the green tea made of green tea (Camellia sinensis var.Yabukita) leaf and by moisture
Content is adjusted to 40 weight %.It is inoculated with 5 × 10 herein6The bacillus subtilis (Bacillus subtillis) of cfu/g, 50
DEG C fermentation 3 days after, fermented at 80 DEG C 4 days.It is 4 weights to be dried the tea of fermentation to moisture with 70 DEG C to 80 DEG C of hot winds
After measuring % to 6 weight %, cured at 10 DEG C 100 days.
The tea sample of above-mentioned curing is crushed 15 seconds, is sieved with the stainless steel of mesh size 1mm.Then, by powder
Broken 50mg is added in the microcentrifugal tube (Eppendorf tube) of 1.5ml, adds the deionized water of 1ml, in 60 DEG C of perseverances
After being stirred 30 minutes with constant speed in warm water tank, centrifugation in 15 minutes has been carried out with 13000rpm at 25 DEG C.From drying
Fermentation green-tea extract in only detached part not soluble in water.
<Embodiment 2>Fraction acquisition is detached with compound
The above-mentioned post-fermented tea sample of 150g is fractionated with acetone and is eliminated as much as catechin-derived object and coffee
Cause obtains the soluble matter of flavonoids concentration.For the above-mentioned acetone soluble matter of 40g, using silica gel column chromatography, by chloroform:Methanol
Mixture as solvent, with 10:1,5:1,1:The sequence of 1 (v/v), which is dissolved out, has obtained each fraction.
Herein, with high performance liquid chromatography (high performance liquid chromatography, HPLC,
Waters Alliance 2695system, Waters, USA) to the chloroform of 12g:Methanol 10:1 (v/v) fraction is analyzed
As a result, in the case where not being fractionated as described above with acetone, it is still caffeine and exists as main compound, as above
Confirm that caffeine has removed (Fig. 1) after the fractionation using acetone.
Utilize high capacity highly effective adverse current chromatogram (high-performance countercurrent
Chromatography, HPCCC, Dynamic Extractions Ltd, UK) it is fractionated the chloroform for eliminating caffeine of 8.9g:
Methanol 10:1 (v/v) fraction.At this moment the solvent used is n-hexane-TBME (methyl tertiary butyl ether(MTBE))-BuOH-MeCN- water
(0.25:3:1:1:5, v/v), flow velocity 25ml/min.Using above-mentioned condition, totally 10 sub- fractions (Fig. 2) are separated, HPLC is used
It is analyzed, it is thus identified that the compound contained by each fraction is largely flavonoids (flavonoid) system (Fig. 3, Fig. 4).
Trans- -3-O- galloyls -3,3 ', 5,5 ', 7- penta hydroxy group flavane (Trans-3-O- are isolated by above-mentioned fraction
galloyl-3,3',5,5',7-pentahydroxyflavan,C22H18O10, molecular weight 442.0900), the compound of separation
Structure is as follows.
[Chemical formula 2]
1In the case of H nuclear magnetic resonance (nuclear magnetic resonance, NMR), as solvent
(solvent) methanol-d3 (methanol-d3) has been used, equipment has used Bruker Advance DPX-500, and (BRUKER is public
Department, USA), trans- galloyl-3-3-O-, 3 ', 5, the NMR data of 5 ', 7- penta hydroxy group flavane is as follows, specific chart such as Fig. 5.
1H NMRδ(500Hz)7.01(s,2H),6.89(s,1H),6.76(s,2H),6.04(s,1H),5.96(s,1H),
5.36(m,1H),5.13(m,1H),2.83(m,1H),2.73(m,1H)
<Experimental example 1>Skin moisturization is evaluated
In order to understand above-mentioned trans- galloyl-3-3-O-, 3 ', 5, the skin moisturization of 5 ', 7- penta hydroxy group flavane will be above-mentioned
Trans- -3-O- galloyls -3,3 ', 5,5 ', 7- penta hydroxy group flavane are coated on 20~30 years old of 14 (man 7, woman 7) health
3 positions of the lower facies medialis brachii 3X3 ㎝ squares of adult men and women.
Specifically, as substances, by above-mentioned trans- galloyl-3-3-O-, 3 ', 5,5 ', 7- penta hydroxy groups flavane with
0.2% concentration is diluted and uses, and as positive controls, has used glycerine 5%.At the initial stage of substances, under
State method skin moisture tester (Corneometer CM825 (Courage+Khazaka electronic GmbH, moral
State)) determine 2 days after, the moisture of skin amount after 7 days, after 11 days.
The measuring principle of skin moisture tester is, for the amount of existing moisture in the epidermis of skin, to utilize electrical side
Method measures the ion degree of moisture, the amount of moisture is quantized and calculated, to measure moisturizing power.First, wanting to survey
The detector (probe) of skin moisture tester is placed on fixed skin part.Pass through sensing when squeezing skin with detector
Device and the conductivity of skin are quantized and are shown on picture, 3 times are repeatedly measured at each position and find out average value.It is tied
Fruit is shown in following table 1.
[Table 1]
It can confirm from above-mentioned table, when by trans- galloyl-3-3-O-, 3 ', 5,5 ', 7- penta hydroxy group flavane is coated on skin
When, moisture of skin amount shows statistically significantly increased trend (paired-samples T-test (paired T-test), p<0.01), exist
Coating also maintains moisture of skin amount after 11 days.Therefore, it is known that according to this specification include trans- galloyl-3-3-O-, 3 ', 5,
The composition of 5 ', 7- penta hydroxy group flavane effectively preserves the moisture of skin after coating and skin moisture-keeping power is excellent.
<Dosage form example 1>Soft capsule
To post-fermented tea acetone fraction 150mg, lactose 440mg, the cornstarch according to this specification embodiment 2
430mg and magnesium stearate 2mg are mixed and have been manufactured soft capsule filling liquid.In addition, above-mentioned steps are different from, with gelatin 66
The ratio of 10 parts by weight of parts by weight, 24 parts by weight of glycerine and Sorbitol solution manufactures soft balsam capsule skin, fills above-mentioned filling liquid, to
Soft capsule is manufactured.
In addition, to trans- galloyl-3-3-O- according to this specification embodiment, 3 ', 5,5 ', 7- penta hydroxy group flavane 3mg, breast
Sugared 440mg, cornstarch 450mg and magnesium stearate 2mg are mixed and are manufactured soft capsule filling liquid.Moreover, with above-mentioned side
Legal system makes soft capsule skin, fills above-mentioned filling liquid, to manufacture soft capsule.
<Dosage form example 2>Tablet
To post-fermented tea acetone fraction 150mg, vitamin e1 5mg, the vitamin C according to this specification embodiment 2
15mg, galactooligosaccharicomposition 250mg, lactose 60mg and maltose 140mg are mixed, and are granulated using fluid bed dryer
Afterwards, it is added to sugar ester (sugar ester) 8mg.The composition is subjected to film-making with usual way and has manufactured tablet.
In addition, to trans- galloyl-3-3-O- of embodiment, 3 ', 5,5 ', 7- penta hydroxy group flavane 3mg, vitamin E 15mg,
Vitamin C 15mg, galactooligosaccharicomposition 259mg, lactose 60mg and maltose 140mg are mixed, using fluid bed dryer into
After row granulating, it is added to sugar ester (sugar ester) 8mg.The composition is subjected to film-making with conventional method and has manufactured piece
Agent.
<Dosage form example 3>Potus
To post-fermented tea acetone fraction 80mg, vitamin E 9mg, the vitamin C according to this specification embodiment 2
After 9mg, glucose 10g, citric acid 0.6g and liquid oligosaccharides 25g are mixed, the pure water that 400ml is added is filled.
After being filled into bottle, sterilizes 4~5 seconds at 30 DEG C and manufactured potus.
In addition, to trans- galloyl-3-3-O- of embodiment, 3 ', 5,5 ', 7- penta hydroxy group flavane 0.1mg, vitamin E 9mg,
After vitamin C 9mg, glucose 10g, citric acid 0.6g and liquid oligosaccharides 25g are mixed, the pure water of 400ml is added, with
The mode of every bottle of 200ml is filled.It sterilizes 4~5 seconds at 30 DEG C after being filled into bottle and has manufactured potus.
<Dosage form example 4>Granule
To post-fermented tea acetone fraction 150mg, vitamin E 9mg, the vitamin C according to this specification embodiment 2
9mg, anhydrous crystal glucose 250mg and starch 550mg are mixed, after being shaped to particle using fluid bed granulate machine, filling
Granule has been manufactured in bag.
In addition, to trans- galloyl-3-3-O- of embodiment, 3 ', 5,5 ', 7- penta hydroxy group flavane 3mg, vitamin E 9mg, dimension
Raw element C 9mg, anhydrous crystal glucose 250mg and starch 550mg are mixed, and particle is shaped to using fluid bed granulate machine
Afterwards, it is filled into bag and has manufactured granule.
<Dosage form example 5>Injection
Composition recorded in following table 2 has manufactured injection with conventional method.
[Table 2]
Gradation composition | Content |
According to the post-fermented tea acetone fraction of embodiment 2 | 100mg |
Injection sterile purified water | In right amount |
PH adjusting agent | In right amount |
In addition, trans- galloyl-3-3-O- of the embodiment using 3mg, 3 ', 5,5 ', 7- penta hydroxy group flavane replace it is above-mentioned after
Fermented tea acetone fraction and manufactured injection.
<Dosage form example 6>Healthy food
According to the composition described in following Table 3, healthy food has been manufactured with conventional method.
[Table 3]
In addition, trans- galloyl-3-3-O- of the embodiment using 3mg, 3 ', 5,5 ', 7- penta hydroxy group flavane replace it is above-mentioned after
Fermented tea acetone fraction, to manufacture healthy food.
About the ratio of components of said vitamin and inanimate matter mixture, to be relatively suitble to the ingredient of healthy food as an example
And composition is mixed, but its match ratio can be implemented with random variation, be mixed according to conventional healthy food manufacturing method above-mentioned
After ingredient, it is used for according to the conventional method in health food composition manufacture.
<Dosage form example 7>Healthy beverage
[Table 4]
Ingredient | Content |
According to the post-fermented tea acetone fraction of embodiment 2 | 50mg |
Citric acid | 1000mg |
Oligosaccharide | 100g |
Plum fruit concentrate | 2g |
Taurine | 1g |
Pure water | Surplus |
Total volume | 900ml |
As shown in Table 4 above, the pure water for adding surplus makes total volume become 900ml, according to conventional healthy beverage
After manufacturing method mixes above-mentioned ingredient, after 85 DEG C of agitating and heatings about 1 hour, manufactured solution is filtered, is taken to the 2 of sterilizing
It rises in container, after sealing sterilizing, refrigeration keeping, to manufacture healthy beverage.
In addition, trans- galloyl-3-3-O- of the embodiment using 0.1mg, 3 ', 5,5 ', 7- penta hydroxy group flavane replaces above-mentioned
Post-fermented tea acetone fraction, to manufacture healthy beverage.
<Dosage form example 8>Smoothing toner (moisturizing lotion)
Utilize 3 weight % of post-fermented tea acetone fraction, the L-AA -2- phosphoric acid magnesium salts 1.00 according to embodiment 2
Weight %, water solubility collagen (1% aqueous solution) 1.00 weight %, 0.10 weight % of sodium citrate, 0.05 weight of citric acid
Amount %, 0.20 weight % of licorice, 3.00 weight % of 1,3-BDO, surplus pure water manufactured smoothing toner (moisturizing
Lotion).
In addition, trans- galloyl-3-3-O- of the embodiment using 0.1 weight %, 3 ', 5,5 ', 7- penta hydroxy group flavane replaces
Above-mentioned post-fermented tea acetone fraction, to manufacture smoothing toner.
<Dosage form example 9>White type preparation
Use 3.00 weight % of post-fermented tea acetone fraction, the polyethylene glycol mono stearate 2.00 according to embodiment 2
Weight %, 5.00 weight % of self-emulsifying glycerol monostearate, 4.00 weight % of propylene glycol, 6.00 weight % of squalene, three -2- second
6.00 weight % of base hexane glyceride, 1.00 weight % of glycosyl sphingolipid, 7.00 weight % of 1,3-BDO, 5.00 weight % of beeswax,
The pure water of surplus, to manufacture white type preparation.
In addition, using trans- galloyl-3-3-O- of the O.1 embodiment of weight %, 3 ', 5,5 ', 7- penta hydroxy group flavane replaces
Above-mentioned post-fermented tea acetone fraction, to manufacture white type preparation.
<Dosage form example 10>Facial mask
Using according to the 3.00 weight % of post-fermented tea acetone fraction of embodiment 2,13.00 weight %, L- of polyvinyl alcohol
1.00 weight % of ascorbic acid -2- phosphoric acid magnesium salts, 1.00 weight % of lauroyl hydroxyproline, (1% is water-soluble for water-soluble collagen
Liquid) 2.00 weight %, 3.00 weight % of 1,3-BDO, 5.00 weight % of ethyl alcohol, surplus pure water, to manufacture face
Film.
In addition, trans- galloyl-3-3-O- of the embodiment using 0.1 weight %, 3 ', 5,5 ', 7- penta hydroxy group flavane replaces
Above-mentioned post-fermented tea acetone fraction, to manufacture facial mask.
The specific part of this specification is illustrated in detail above, to those skilled in the art, this
The specific technology of kind is preferred embodiment, and it is obvious that the range of this specification, which will not be defined in this,.Therefore, this explanation
The substantial range of book is based on appended claims and its equivalent is defined.
Claims (11)
1. a kind of Hydra composition, contain galloyl -3 3-O- indicated by following chemical formula 1,3 ', 5,5 ', 7- penta hydroxy groups are yellow
Alkane, its isomers, its acceptable salt, its prodrug, its hydrate, its solvate are fractionated comprising its post-fermented tea ketone
Object as active ingredient,
Chemical formula 1
2. composition according to claim 1, wherein the post-fermented tea ketone fraction is for the non-aqueous of post-fermented tea
The ketone fraction of soluble extract.
3. composition according to claim 1, wherein the ketone is acetone.
4. composition according to claim 1, wherein galloyl -3 3-O-, 3 ', 5,5 ', 7- penta hydroxy group flavane is served as reasons
Trans- galloyl-3-3-O- that following chemical formula 2 indicates, 3 ', 5,5 ', 7- penta hydroxy group flavane,
Chemical formula 2
5. composition according to claim 1, wherein in the composition, galloyl -3 3-O-, 3 ', 5,5 ', 7- pentahydroxy-s
Base flavane, its isomers, its acceptable salt, its prodrug, its hydrate or its solvate content relative to the combination
Object total weight is 0.000001 weight % to 5 weight %.
6. composition according to claim 1, wherein in the composition, the content phase of post-fermented tea ketone fraction
It is 0.01 weight % to 100 weight % for the composition total weight.
7. composition according to claim 1, wherein in the fraction, galloyl -3 3-O-, 3 ', 5,5 ', 7-
Penta hydroxy group flavane, its isomers, its acceptable salt, its prodrug, its hydrate or its solvate are with fraction total weight
Benchmark includes 0.0001 weight % to 5 weight %.
8. composition according to claim 1, wherein galloyl -3 3-O-, 3 ', 5,5 ', 7- penta hydroxy groups flavane, its is different
Structure body, its acceptable salt, its prodrug, its hydrate or its solvate dosage be 0.0001mg/kg/ days to 15mg/
Kg/ days.
9. composition according to any one of claim 1 to 8, wherein the composition is food compositions.
10. composition according to any one of claim 1 to 8, wherein the composition is pharmaceutical composition.
11. composition according to any one of claim 1 to 8, wherein the composition is cosmetic composition.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020160092229A KR102635190B1 (en) | 2016-07-20 | 2016-07-20 | Composition for moisturing skin comprising trans-3-O-galloyl-3,3',5,5',7- pentahydroxyflavan |
KR10-2016-0092229 | 2016-07-20 | ||
PCT/KR2017/007294 WO2018016783A1 (en) | 2016-07-20 | 2017-07-07 | Moisturizing composition containing 3-o-galloyl-3,3',5,5',7-pentahydroxyflavan |
Publications (2)
Publication Number | Publication Date |
---|---|
CN108697143A true CN108697143A (en) | 2018-10-23 |
CN108697143B CN108697143B (en) | 2023-09-12 |
Family
ID=60993153
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201780013667.7A Active CN108697143B (en) | 2016-07-20 | 2017-07-07 | Moisturizing compositions comprising 3-O-galloyl-3,3', 5',7-pentahydroxyflavan |
Country Status (5)
Country | Link |
---|---|
JP (1) | JP7030692B2 (en) |
KR (1) | KR102635190B1 (en) |
CN (1) | CN108697143B (en) |
HK (1) | HK1254516A1 (en) |
WO (1) | WO2018016783A1 (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN116162078A (en) * | 2022-12-27 | 2023-05-26 | 佛山病原微生物研究院 | Epigallocatechin gallate compound and preparation method and application thereof |
Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20070021384A1 (en) * | 2004-07-06 | 2007-01-25 | School Of Pharmacy, University Of London | Compounds for use in the treatment of infection |
US20100316748A1 (en) * | 2007-10-26 | 2010-12-16 | Gerda Fouche | Management and treatment of benign prostatic hyperplasia |
KR20120021407A (en) * | 2010-07-30 | 2012-03-09 | 주식회사 비티씨 | Composition for antioxidation, skin brightening and antiaging which comprises green tea hydrosate as an active ingredient |
KR20120021709A (en) * | 2010-08-13 | 2012-03-09 | (주)아모레퍼시픽 | Cosmetic composition containing flavonoid derivatives |
CN103610633A (en) * | 2013-10-11 | 2014-03-05 | 芽美化妆品有限公司 | Cosmetic material composition containing ginseng fruit-pleuratus ferulae fermentation liquid |
WO2016093515A1 (en) * | 2014-12-09 | 2016-06-16 | (주)아모레퍼시픽 | Composition for activating longevity gene |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR100975199B1 (en) | 2007-11-30 | 2010-08-10 | (주)아모레퍼시픽 | Method for manufacturing fermented green tea, and green tea therefrom |
-
2016
- 2016-07-20 KR KR1020160092229A patent/KR102635190B1/en active IP Right Grant
-
2017
- 2017-07-07 JP JP2018526252A patent/JP7030692B2/en active Active
- 2017-07-07 WO PCT/KR2017/007294 patent/WO2018016783A1/en active Application Filing
- 2017-07-07 CN CN201780013667.7A patent/CN108697143B/en active Active
-
2018
- 2018-10-29 HK HK18113766.5A patent/HK1254516A1/en unknown
Patent Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20070021384A1 (en) * | 2004-07-06 | 2007-01-25 | School Of Pharmacy, University Of London | Compounds for use in the treatment of infection |
US20100316748A1 (en) * | 2007-10-26 | 2010-12-16 | Gerda Fouche | Management and treatment of benign prostatic hyperplasia |
KR20120021407A (en) * | 2010-07-30 | 2012-03-09 | 주식회사 비티씨 | Composition for antioxidation, skin brightening and antiaging which comprises green tea hydrosate as an active ingredient |
KR20120021709A (en) * | 2010-08-13 | 2012-03-09 | (주)아모레퍼시픽 | Cosmetic composition containing flavonoid derivatives |
CN103610633A (en) * | 2013-10-11 | 2014-03-05 | 芽美化妆品有限公司 | Cosmetic material composition containing ginseng fruit-pleuratus ferulae fermentation liquid |
WO2016093515A1 (en) * | 2014-12-09 | 2016-06-16 | (주)아모레퍼시픽 | Composition for activating longevity gene |
Non-Patent Citations (3)
Title |
---|
田丽丽,等: "茶多酚在化妆品中的研究进展", 《广东茶业》 * |
邓小锋,等: "表没食子儿茶素没食子酸酯在化妆品中的功效机理", 《日用化学工业》 * |
龙丹,等: "儿茶素类的保健作用及机制", 《食品安全质量检测学报》 * |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN116162078A (en) * | 2022-12-27 | 2023-05-26 | 佛山病原微生物研究院 | Epigallocatechin gallate compound and preparation method and application thereof |
Also Published As
Publication number | Publication date |
---|---|
WO2018016783A1 (en) | 2018-01-25 |
HK1254516A1 (en) | 2019-07-19 |
CN108697143B (en) | 2023-09-12 |
JP2019520786A (en) | 2019-07-25 |
JP7030692B2 (en) | 2022-03-07 |
KR20180010084A (en) | 2018-01-30 |
KR102635190B1 (en) | 2024-02-13 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN103025311B (en) | As the carbamic acid menthyl ester compound of skin and/or hair whitening active thing | |
JP6847871B2 (en) | Aqueous solution containing urolithins, a dry solid composition thereof, a method for producing them, and a method for stabilizing urolithins. | |
JP2019001739A (en) | Application of cyclodextran and derivative of the same | |
JP2009263275A (en) | Antioxidant and cosmetic product, food and drink composition and pharmaceutical composition containing the same | |
JP2008291004A (en) | Composition for beautiful skin | |
KR20130069512A (en) | Skin external composition comprising tangeretin | |
JP4298204B2 (en) | Atopic dermatitis treatment | |
CN108697143A (en) | Including 3-O- galloyls -3,3 ', the Hydra composition of 5,5 ', 7- penta hydroxy group flavane | |
US11306117B2 (en) | Whitening composition containing novel quercetin-based compound | |
CN106852725A (en) | Composition for improving skin | |
KR102496282B1 (en) | Composition for anti-aging comprising cytochalasin d or sag and method for screening anti-aging substances | |
US11248017B2 (en) | Anti-inflammatory composition including novel kaempferol-based compound derived from post-fermented tea | |
CN114269333A (en) | Cannabidiolate for use in cosmetic or edible compositions | |
JP5835894B2 (en) | Tyrosinase activity inhibitor, melanin production inhibitor and whitening agent, and cosmetics, food and beverage compositions and pharmaceutical compositions containing them | |
JP5525716B2 (en) | Pigmentation inhibitor | |
EP4088712A1 (en) | Composition for stimulating and inducing changes in environment around aging skin cells | |
JP7121758B2 (en) | Whitening composition containing novel kaempferol compound derived from post-fermented tea | |
JP6732495B2 (en) | Composition for suppressing sebum secretion | |
JP2006083115A (en) | Skin-beautifying composition | |
JP2017088538A (en) | Filaggrin production promoter | |
JP6646408B2 (en) | Ceramide production promoter | |
TW202038899A (en) | Composition containing stilbenoid glycoside and hydrotrope | |
KR20210118272A (en) | A composition comprising kakkalide | |
KR20180020493A (en) | Composition for anti-oxidation or anti-aging comprising 3-O-galloyl-3,3',5,5',7- pentahydroxyflavan | |
JP2006096669A (en) | Skin-beautifying composition |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
REG | Reference to a national code |
Ref country code: HK Ref legal event code: DE Ref document number: 1254516 Country of ref document: HK |
|
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant |